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ABSTRACT

ACTIVE INHIBITION OF T CELL PROLIFERATION BY MONOCYTES

by
Dean Anthony Lee

Monoclonal antibodies (mAb) to MHC class II molecules (anti
class II mAb) have been well described in their ability to inhibit T cell
activation. The most current model is that anti-class II mAb interfere
directly with the T cell receptor-major histocompatibility complex
crosslinking which is necessary for T cell activation. The anti-CDS
mAb, OKT3, is an MHC class II molecule-independent mitogen which
causes T cell activation by direct ligation of the TCR-CD3 complex.
OKT3 and a panel of anti-class II mAb were used to dissect the
individual roles played by these two receptors in activation and
inhibition of peripheral blood mononuclear cells. In this study, it is
shown that the inhibition of OKT3-dependent T cell activation
correlates with metabolic activation of antigen presenting cells. In
contrast, inhibition of lectin- and superantigen-mediated T cell
activation may occur without activation of antigen presenting cells. It
is also shown that the anti-class II mAb that inhibit OKT3-mediated T

cell activation also induce tyrosine phosphorylation, metabolic
activation of adherent mononuclear cells, heterotypic cell aggregation,
and formation of multinucleated giant cells. One mAb, 417, was
previously shown by Dr. G. A. Molinaro to inhibit lectin-mediated T cell
activation, but was unable to inhibit OKT3-mediated activation. All
other anti-class II mAb which were tested inhibit all forms of T cell
activation. Thus, it is also shown that 417 does not induce tyrosine
phosphorylation or metabolic activation, and that the inability of mAb
417 to inhibit OKT3 activation is not dependent on the IgM isotype or
MHC subclass specificity. Using cell culture inserts, solid-phase anti
class II mAb are shown to induce the release of a soluble inhibitory
factor from mononuclear cells. Finally, flow cytometry, fluorescent
microscopy, and gel electrophoresis were used to show that ligation of
MHC class II molecules on antigen presenting cells induces activationdependent apoptosis of T cells. The author proposes that antigen
presenting cells may be the discriminating factor between activation
and deletion in the avidity models of T cell selection and peripheral
tolerance.
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CHAPTER 1
INTRODUCTION
1.1

Thymus (T) Cell Signal Transduction
Signal transduction is a common problem basic to the biology of

all cells, involving the transmission of signals from cell to cell, from
extracellular to intracellular, and from the cytoplasm to the nucleus.
T cell activation, with its inherent complexities in thymic development,
peripheral activation, and tolerance, is one of the most studied
eukaryotic models of signal transduction. One way of studying cell
activation is by examining inhibition of the activation process at
different positions in the signal transduction cascade, e.g., surface
receptor ligation, generation of second messengers, activation of
nuclear binding proteins.
The major histocompatibility complex molecules (MHC) plays an
important role in T cell activation by presenting antigen (Ag) peptides.
Monoclonal antibodies (mAb) to MHC inhibit the activation of a variety
of T cell activators, which include Ag-peptides, allogeneic MHC, mAb
directed against the T cell receptor (TCR) or cluster of differentiation
antigen (CD)3 complex, superantigens (sAg), and lectins (Geha et al.,
1981; Issekutz et al., 1982). I have used concanavalin A (ConA)
staphylococcal enterotoxin A (SEA) and mAb OKT3 as activators and
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anti-MHC mAb as inhibitors to examine the events of T cell activation
and inhibition and the relative roles played by class II molecules and
the TCR.

1.1.1 Antigen-mediated activation
In the Ag-mediated stimulation of T cells, two required signals
have been identified. One signal is provided by the interaction of the
TCR-CD3 complex of the T cell with the Ag-MHC complex of the antigen
presenting cell (ARC) (Zinkemagel and Doherty, 1974). The second
signal may be provided by the interaction of CD28 on the T cell with
surface-bound B7 or soluble interleukin (IL-lp) produced by the
interacting ARC (Gimmi et al., 1991). These two signals are transduced
and integrated by the cooperative activation of three distinct protein
tyrosine kinases, namely p56lck, p59fyn, and ZAP70. The p56lck is
associated with CD4 and CDS (Rudd et al., 1988, Barber et al., 1989),
and is activated by TCR-CD3 aggregation, but not by dimerization only
(Ratcliffe et al., 1992). The p56lck may also be activated by CD4
crosslinking (Veillette et al., 1989). The p59fyn is physically associated
with the CD3-t chains of the TCR (Baldari et al., 1995). Finally, ZAP70
also becomes associated with the CD3-£ chain of the TCR after
stimulation (Koyasu et al., 1994), and tyrosine-phosphorylates the

3

£ chain and phospholipase-C within seconds of the initial stimulus
(Chan et al., 1991).
Activation of phospholipase-C is mediated by one or more of
these tyrosine kinases as crosslinking of the TCR brings multiple
kinases into apposition and initiates the phosphorylation cascade
(Mustelin et al., 1990). Activation of phospholipase-C generates
diacylglycerol and inositol phosphates (primarily inositol triphosphate).
These mediators then increase the intracellular calcium concentration
through both extracellular influx and release from intracellular stores.
These signals may be partially replaced, however, by phorbol
esters and Ca++ ionophores (Weiss, 1993). These agents directly
induce tyrosine phosphorylation and influx of Ca++, bypassing the
surface receptors involved in T cell activation. Notably, a second signal
of IL-1(3 or B7 is still required, in addition to the phorbol ester and
ionophore, for sustained activation and proliferation of T cells.
There is more than one pathway of T cell activation. In mature
T cells, quantitative differences in intracellular Ca++ flux and cytokine
release (Liu et al., 1991) have been shown between the signal
transduction triggered by conventional antigen and superantigen.
Similar differences at the level of inositol triphosphate production have
been shown between alloantigen and minor lymphocyte stimulating

4
antigen activation (O'Rourke et al., 1990). In immature T cells,
different activation pathways seem necessary a priori, as cells with the
same TCR may mature or die based on the type of signal received
through TCR ligation during their development. In support of this,
there is evidence that p56lck activation is involved in thymic positive
but not thymic negative selection (Nakayama et al., 1992).
Tyrosine phosphorylation is an early and common signal
transduction mechanism, and phosphorylated tyrosine can easily be
distinguished from serine-threonine phosphoproteins with
phosphotyrosine-specific mAb (Glenney et al., 1988). Identification of
the various substrates of tyrosine phosphorylation can aid the study of
events downstream of tyrosine kinase activation.
The earliest extracellular activation signal, TCR crosslinking,
results in the downstream signal of an increase in stable messenger
RNA for c-fos, while the second extracellular signal, IL-1 binding, leads
to an increase in c-jun messenger RNA (Muegge et al., 1989). The
products of both of these genes are transcription factors for the
activation of AP-1, a promoter for IL-2 transcription, which is a
hallmark of T-cell activation (Muegge et al., 1989). Another early event
of T cell activation is the expression of Fas antigen within 4 hours of
TCR stimulation (Herron et al., 1993). In contrast, the surface
expression of class II molecules in activated human T cells is not

5

detectable until the third day, and is not optimal until day 6-7 (Ko et
al., 1979).

1.1.2 Mechanisms of mitogenic activation
The functional requirement of class II molecules on the APC for
Ag-dependent activation of T cells is to present Ag peptide to the TCR
for ligation of the TCR and CD4 molecules. In the mitogen-dependent
activation of T cells, however, it is known that APC are needed, but the
role of the class II molecules has not been well established. The
ability of anti-class II mAb to inhibit the T cell proliferation mediated
by mitogens including OKT3 has been described in support of a direct
involvement of class II molecules (Akiyama et al., 1985).
In the activation mediated by OKT3 and ConA, it has been shown
that APC are required, but it is not known if these activators use the
same cellular mechanisms for T cell activation, nor if their
requirements for APC have a similar basis. The a) ubiquitous ligands
of ConA in contrast to the specificity of OKT3 for CD3, b) recent papers
describing differences in signal transduction (O’Rourke et al., 1990),
and c) the initial finding in this laboratory of a mAb that can inhibit
Con A but not OKT3 activation, all suggest that these mitogens may
have different mechanisms of activation.

6

1.1.3 MHC-dependent vs. MHC-independent activation
In T cell activation mediated by superantigen, there is no cognate
interaction between TCR and Ag-MHC, as clearly shown by the fact that
SEA binds all MHC class II molecules via a monomorphic epitope
(Fraser et al., 1993). Superantigens are able to stimulate CD8+ cells
despite the fact that these cells are class I-restricted and sAg are not
known to bind to class I (Rich et al., 1989). Even xenogeneic ARC can
support sAg-mediated T cell activation (Fleischer et al., 1991).
The affinity of sAg for class II molecules plays a role in T cell
activation. Among four major staphylococcal sAg (SEA, staphylococcal
enterotoxin B, staphylococcal enter©toxin Cl, and toxic shock
syndrome toxin-1), there was an inverse correlation between affinity
and mitogenic dose (Mollick et al., 1991). Of significance is the fact
that the affinities of these sAg for class II molecules varied less than
6-fold. In contrast, the mitogenic doses varied more than two orders of
magnitude. In each case, however, the mitogenic dose for all sAg was
shown to complex approximately 0.1% of the surface class II molecules
on monocytes. Thus, it seems that the level of class II molecule
signaling mediated by sAg is restricted to a narrow range.
In contrast, activation of T cells by anti-CD3 mAb (OKT3) is not
dependent on MHC signaling, but is dependant on the binding of the
mAb to FcRI, based on data from four healthy subjects that were

7

unresponsive to soluble OKT3, and were shown to be FcRI deficient
(Ceuppens et al., 1988). Presumably, the role of FcRI binding is to
promote efficient aggregation of the TCR-CD3 complex, and therefore
initiate T cell activation independent of MHC. This MHC-independence
is further supported by the ability of solid-phase OKT3 to initiate T cell
proliferation in the absence of class II molecule+ cells, as long as a
suitable second signal, such as IL-2, is provided (Bentin et al., 1991).
Lectins are proteins with affinity for glycoproteins bearing
specific carbohydrate side chains. ConA, a mitogenic lectin, is a
homotetramer that specifically binds a-D-mannose glycoproteins. The
large number of a-D-mannose bearing glycoproteins on the surface of
leukocytes have made it difficult to identify the surface molecules
required for ConA-mediated activation.

1.1.4 Altered peptide ligands (APL)
The role of peptides in the TCR-Ag-MHC interaction that leads to
T cell activation can be studied with analogs of the nominal activating
peptide (termed altered-peptide ligands (APL)). APL have recently
become a powerful tool for studying the development of immature
thymocytes and the response of mature lymphocytes in vivo with TCRtransgenic mice or in vitro with T cell clones.
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Some APL created by a single amino acid change from the
nominal peptide are unable to activate the relevant T cells (DeMagistris et al., 1992), while others lose the ability to induce T cell
proliferation but still elicit the early events of T cell activation such as
IL-2 receptor upregulation, IL-4 production, increased cell volume,
B cell help, or cytolytic function (Evavold et al., 1991, Sloan-Lancaster
et al., 1993). Some other APL, when presented with the nominal
peptide, behave as antagonists since they can inhibit the proliferation
induced by the nominal peptide alone (De-Magistris et al., 1992). This
antagonism is not by competition for the MHC groove since
antagonistic peptides can also inhibit the activation mediated by sAg
(Evavold et al., 1994), that binds to external epitopes outside of the
MHC groove.

1.2

Class II molecules
MHC class II molecules are ap heterodimers in the

immunoglobulin superfamily. Each of the a and (3 chains has a
proximal extracellular immunoglobulin (Ig) domain, a distal Ag-binding
non-Ig domain, a transmembrane region, and an intracellular domain.
Carbohydrate side chains are present in the short linker regions
between the two extracellular domains. These domains may contain
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sialylated (bi, tri, or tetra-antennaiy) or high mannose side chains
(Krangel et aL, 1979). Although class I and class II molecules are
similar in structure, the linker regions between the extracellular
domains of class I are fucosylated only (Merlu et aL, 1989). While the
mechanism for activation has not been described, these data suggest
that ConA may crosslink by binding to class II molecules via these
carbohydrate chains. In contrast, sAg binds globulin-domain epitopes
that are sAg specific, and Ag peptides are bound for presentation to
T cells by the distal part of the extracellular region of class II
molecules in the region known as “the groove”.

1.2.1 Signal transduction through class II molecules
It has been shown that anti-class II mAb can activate B cells
(Sauerwein et al., 1988). Staphylococcal enterotoxins have also been
shown to induce signal transduction through MHC (Mourad et al.,
1993). This signal transduction parallels, in many ways, signal
transduction through the TCR. As with TCR crosslinking, class II
molecule crosslinking activates src-family tyrosine kinases (Morio et
al., 1994). While other monocyte stimuli may increase expression of
IL-lp and IL2-R, class II molecule ligation with sAg selectively induces
expression of IL-lp and tumor necrosis factor-a (al-Daccak et al., 1994,
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Trede et al., 1991). Expression of these cytokines requires tyrosine
phosphorylation (Brick-Ghannam et al., 1991, Palkama and Hurme,
1993). Messenger RNA for c-jun and c-fos are also increased following
sAg ligation of class II molecules (Trede et al., 1991). These proteins
then combine as the subunits of the transcriptional activator AP-1,
which initiates IL-2 transcription in T cells. Surprisingly, these
proteins also appear to be important in the binding of transcriptional
activators for the expression of class II itself (Ombra et al., 1993)
creating a positive feedback for class II molecule expression in
response to class II molecule ligation. This is consistent with
previous findings that leukocytes (T cells, B cells, and monocytes)
upregulate MHC expression as a response to activation (Collins et al.,
1991).
Signal transduction through class II molecules ultimately results
in several phenotypic changes in B cells, such as homotypic
aggregation (Ramirez et al., 1992) and enhanced proliferation mediated
by IL-4 (Ramirez et al., 1993).

1.2.2 Inhibition of T cell proliferation by anti-class II mAb
Anti-class II mAb inhibits both OKT3- and Con A-media ted
activation of T cells (Akiyama et al., 1985). However, Molinaro
(personal communication) observed that one anti-class II mAb, mAb
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417, inhibited Con A- but not OKT3-mediated activation. This finding
suggests that there might be more than one mechanism of T cell
inhibition, dependent on the mitogen used for activation. The serologic
distinction between polymorphic and monomorphic epitopes is mirrored
by a structural and functional distinction, as the polymorphic epitopes
are located in the peptide-binding groove of the MHC, while the
monomorphic epitopes mostly represent the conserved sequences
involved in the interaction of MHC with T cell surface antigens such as
TCR, CD3, or CD4 (Marsh and Bodmer, 1989). One possibility is that
the different inhibitory activities of anti-class II mAb depend on their
specificity for different epitopes of class II molecules. Functional
differences have been described both within the class II family (e.g.,
polymorphic vs. monomorphic) and between class II subclasses (e.g.,
HLA-DR vs. HLA-DQ) (Ruggiero et al., 1989).
The concept of multiple signal transduction pathways proposed
for T cell activation may also apply to inhibition of T cell activation.
The mechanism of anti-class II mAb inhibition may involve signal
transduction in the APC, resulting in an indirect inhibition of the
T cells. This signaling is evidenced by the phenotypic changes
mentioned previously, e.g. increased cytokine messenger RNA.
The current model of activation inhibition by anti-class II mAb is
that mAb interfere directly, by physical steric hindrance, with the
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interaction between the class II molecule and the TCR complex
(Ruggiero et al., 1991). This model is able to explain the effect of
inhibitory anti-class II mAb on MHC-dependent activators, but does
not explain the inhibition of MHC-independent activation (i.e. OKT3),
nor does it address some of the biochemical, morphologic, or
phenotypic changes seen in ARC in response to anti-class II mAb
(Manzo et al., 1990). In contrast, these responses of ARC to anti-class
II mAb seem to indicate that an active mechanism may be involved in
the inhibition of T cell activation, possibly in addition to the passive
physical mechanism of steric hindrance.

1.3

Thymic Selection
The development of self-tolerance during thymic maturation of

T cells is dependent on the ability to distinguish between at least
three levels of TCR-MHC affinity: low or no affinity leading to non
selection, moderate affinity leading to positive selection, and high
affinity leading to negative selection. Nonselection and negative
selection both lead to elimination of these cells by apoptosis.
Positive selection occurs preferentially on thymic epithelium
(Jacobs et al., 1990, Poirier et al., 1994). It has been suggested that
this is related to the presence of positive factors in the epithelial
microenvironment, however lymphoid cells (Bix and Raulet, 1992) or
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even fibroblasts transfected with MHC may support positive selection
(Pawlowski et aL, 1993).
In contrast, negative selection requires antigen presentation by
thymic bone-marrow derived cells (i.e., stromal cells, dendritic cells)
(Vukmanovik, 1992). Expression of foreign antigens on thymic
epithelium in transgenic animals induces negative selection, but this
appears to be by a mechanism of anergy, not deletion (Kruisbeek,
1993).
The two signal model— that the TCR is able to actively deliver
two different signals depending on the avidity of the interaction— has
been problematic on both theoretical and experimental levels. It is
difficult to propose a model that accounts for qualitatively different
selection signals originating from the same TCR crosslinking. They
may represent identical signals at different stages of thymocyte
maturation, or compound signals reflected in the binding of accessory
molecules. However, both of these models require some level of
receptor "tuning" to account for the fact that the same peptide that
positively selects in the thymus is nonstimulatory in the periphery,
and that the peptide that causes deletion in the thymus is stimulatory
in the periphery. A third possibility to account for this dichotomy is
that positive and negative selection occur in distinct
microenvironments. In this model, it is proposed that different types
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of APC encountered at different times during T cell maturation deliver
different signals through the TCR.
A variation of this model, presented here, is that both positive
and negative selection stimulate signal transduction via the TCR
complex, while only the higher affinity binding that leads to negative
selection is able to stimulate signal transduction via the MHC of
thymic bone marrow-derived cells.
This MHC-dependent activation of APC could override the TCRdependent positive selection via activation of a secondary pathway by
an APC-specific factor. Thus, negative selection in the thymus or in
the periphery may result from a negative cytokine released from APCs
following MHC signaling.
This model is supported by evidence describing a differential role
for APC types in thymic development, described above, and other
evidence which shows that activated B cells can turn off virgin
peripheral T cells, while monocytes appear to be stimulatory only
(Fuchs and Matzinger, 1992).

1.4

Apoptosis
One of the characteristics of apoptosis in vivo is the rapid

recognition and phagocytosis of apoptotic cells by macrophages. This
rapid removal of dying cells prevents a local inflammatory response to
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tissue damage that would occur in sites of high cell death rate such as
the thymus or other lymphoid tissue. Recognition and phagocytosis of
effete lymphocytes by macrophages were first described in the 1890’s by
Metchnikoff (Fadok et al., 1992). There are at least three specific
mechanisms used by macrophages to identify cells in early apoptosis.
Macrophage recognition of apoptotic cells was first shown to be lectin
associated (Duvall et al., 1985). Addition of sugars blocked
phagocytosis in these experiments. More recently described, apoptotic
cells may also be recognized by the sudden appearance of
phosphatidylserine on the surface or expression of a vitronectin
receptor (Akbar et al., 1994). Phosphatidylserine is usually restricted
to the cytoplasmic face of the plasma membrane by an enzyme termed
appropriately, flippase. Curiously, the manner in which apoptotic cells
are recognized seems not to be related to the type of cell undergoing
apoptosis, but to the type of macrophage responsible for the removal of
the apoptotic cell. Peritoneal macrophages recognize apoptotic cells
solely on the presence of phosphatidylserine, while bone marrow or
monocyte-derived macrophages recognize only the vitronectin receptor.
This recognition process appears to be independent of the species
(murine or human) or lineage of the apoptotic cell being phagocytosed
(lymphocyte or neutrophil) (Fadok et al., 1992).
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Finally, the ability of macrophages to recognize apoptotic cells, at
least via phosphatidylserine, is not constitutive, but is inducible by a
number of monocyte activators (Fadok et ah, 1993).

1.4.1 Activation-induced apoptosis
Thymic selection involves programmed cell death— or death by
neglect— if no selection occurs, rescue from apoptosis during positive
selection, or activation-induced apoptosis in negative selection.
There are currently two models for the induction of apoptosis as
a mechanism for clonal deletion: pre-emptive death or the two signal
death-survival model (Green and Scott, 1994). The pre-emptive death
model states that death will be the given result of T cell activation if it
occurs during a specific developmental window. The two signal model
suggests that T cell activation induces a state which may lead to either
proliferation and differentiation or apoptosis, depending upon
additional signals which induce death or survival in the cell.
Activation-induced apoptosis was first observed in developing
thymocytes and has been proposed as a mechanism of negative
selection. Activation-induced apoptosis has recently been
demonstrated in peripheral mature T cells as well, and may represent a
mechanism for either peripheral tolerance or immune regulation as a
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homeostatic mechanism to limit the expansion of lymphocytes specific
for any one antigen (Green and Scott, 1994).
In support of the two-signal model, one of the second signals for
apoptosis in peripheral T cells has been shown to be delivered through
the Fas antigen (Herron et al., 1993), which is upregulated hours after
T cell activation. Mutations in the Fas antigen or its ligand form the
basis for the Ipr and gld autoimmune strains of mice. These mice
demonstrate peripheral T cell populations that are resistant to
activation-induced apoptosis, and this has been used to explain the
basis of their tendency towards autoimmunity. Signaling through the
Fas receptor on T cells is mediated by tyrosine phosphorylation, and
c-myc, a common substrate for phosphorylation and a key proto
oncogene involved in T cell activation, has been show to be essential
for activation-induced apoptosis (Shi et al., 1992).
Despite the many similarities between activation-induced
apoptosis in thymocytes and mature T cells, Fas may not play a role in
thymic negative selection, since lpr+/+ TCR transgenic mice, which lack
Fas, are not deficient in their ability to negatively select against the
transgene TCR (Zhou et al., 1992).
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1.5

Metabolic Activation
Certain cells, notably neutrophils but also other phagocytic cells,

are known to undergo a phenomenon called metabolic burst, which
involves the sudden production of large amounts of reactive oxygen
intermediates (ROI), such as superoxide, hydrogen peroxide, nitric
oxide, and hydroxyl radicals. Production of these ROI are all
dependent on mitochondrial enzymes.
The MTT (3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyl tetrazolium
bromide) assay is a colorimetric assay based on the conversion of a
yellow tetrazolium substrate into a blue formazan product by the
mitochondrial enzyme succinate dehydrogenase (Rai-el-Balhaa et al.,
1985). The number of mitochondria in a cell, and correspondingly, the
amount of mitochondrial dehydrogenase, is generally constant within a
specific cell type. This has led to the widespread use of MTT, and its
derivatives such as 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium (MTS), as reliable indicators
of cell proliferation and/or cell viability as a replacement for
radioisotope-based methods. The assay is cheaper, faster, and easier
than the thymidine incorporation method. However, although it has
excellent internal consistency, the dynamic range is somewhat less
than that of thymidine.
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Several potential conditions are described in which mitochondrial
number does not correlate with proliferation or cell viability. First, the
number of mitochondria per cell may be increased during times of
stress or activation (Ashrafi et al., 1992) This increase in mitochondria
can occur with other signs of metabolic activation (Skotarczak, 1992).
In addition, the activity of mitochondrial dehydrogenases, independent
of mitochondrial number, can be upregulated (Criswell et al., 1993).
Other enzymes with dehydrogenase activity can also be increased in
activated macrophages, such as NO synthase, NADPH diaphorase
(Mitchell et al., 1992), glucose-6-phosphate dehydrogenase (Corraliza
et al., 1993), and NADPH oxidase (cytochrome b559) (Knoller et al.
1991). Notably, all of these enzymes are involved in the generation of
ROI- the first three of these in the production of nitric oxide, the latter
in the production of superoxide.

1.6

Relevant Concepts in HIV Pathogenesis
Class II molecules share amino acid identity and antibody cross

reactivity with at least two of the human immunodeficiency virus (HIV)
proteins, gp41 and gpl20 (Blackburn et al., 1991, Singer et al., 1988).
This is not surprising, since gp41, gpl20, and class II molecules share
a common ligand, CD4. It has been proposed that this identity may
form the basis of a crossreactive autoimmunity that would eventually
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result in a breakdown of the immune system, since class II molecules
are exclusively found on lymphoid cells. This hypothesis, however,
seems contradictory to the clinical symptom of CD4+ T-cell decline in
the presence of apparently normal numbers of APC. MHC cross
reactive antibodies with immunosuppressive potential have been
demonstrated in HIV+ individuals (Zaitseva et al., 1992), but the
mechanism of immunosuppression has not been described.
It has been suggested that progression of HIV infection to AIDS
may not be a simple matter of CD4+ cell depletion by the virus, but
rather may reflect the decline of monocyte-macrophage function, as
these cells are also infected by the virus. However, phagocytic function
of monocytes, with respect to internalization and ROI production, does
not appear to be impaired in HIV (Nottet et al., 1993). Likewise,
cytokine expression in HIV-infected monocytes appears normal.
One of the recent findings in HIV that has helped explain
immune dysfunction is the fact that T cells from HIV+ patients undergo
enhanced apoptosis when cultured overnight, and are more sensitive to
activation-induced apoptosis. However, activation induced apoptosis in
HIV also includes CD8+ cells (Meyaard et al., 1992, Carbonari et al.,
1994), implying a pathology beyond the infection of CD4+ lymphocytes.

CHAPTER 2
METHODS AND REAGENTS
2.1

Cell Lines
AG-1311, a human B cell line derived from a patient with multiple

myeloma; GM-2132, a lambda light chain secreting human B cell line
derived from a patient with multiple myeloma [also known as RPMI
(Roswell Park Memorial Institute) 8226]; and GM-1500, a B cell line
derived from a male patient with IgG myeloma, were all obtained from
the Human Genetic Mutant Cell Repository.
Daudi (CCL 213), a human B cell line derived from a Burkitt's
lymphoma patient, and WI-L2-729HF2 (also known as UCNS (CRL
8062)), a non-secreting, HAT-sensitive, 6-thioguanine-resistant B
lymphoblastoid cell line, were obtained from the American Type Culture
Collection, Rockville, Md.
Jurkat, clone E6-1, a human T cell line derived from a patient
with acute T cell leukemia, was a kind gift of Dr. Jan Wallaczech, Loma
Linda Veterans Administration Hospital, Loma Linda, Ca.
Raji, a B lymphoblastoid cell line derived from a Burkitt's
lymphoma patient, and RJ2.2.5, a mutant of Raji deficient in a nuclear
transcription factor required for expression of MHC class II molecules,
were both the kind gifts of Dr. John Sands.
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WIL-T, a thioguanine sensitive variant of the human
B lymphoblastoid cell line WIL2, was established by Dr. G. A. Molinaro
(Loma Linda University, Loma Linda, Ca.).

2.2

Antibodies
mAbs 80 (IgG2a mouse anti-human MHC class II), 417 (IgM

mouse anti-human MHC class II), 420 (IgGl mouse anti-human MHC
class II), 506 (IgG2a mouse anti-human MHC class II), 718 (IgM mouse
anti-human IgM), B14 (IgGl mouse anti-human b2-microglobulin), and
Q5/13 (IgG2a mouse anti-human MHC class II) were developed by
G. A. Molinaro.
x63, an IgGl from a secreting mouse myeloma cell line (also
known as P3X63Ag8 (TIB 9)), and OKT3 (IgG2a mouse anti-human CD3)
were obtained from the American Type Culture Collection, Rockville,
Md.
mAbs KS5 [IgM mouse anti-human leukocyte antigen (HLA)DQwl], KS11 (IgM mouse anti-HLA-DQwl), and AC1.59 (IgM mouse
anti-HLA-DRl,4,w6,w8,w9) were the kind gifts of Dr. Soldano Ferrone.
mAb PY20 (IgG2b mouse anti-phosphotyrosine), fluorescein
isothiocyanate (FITC)-conjugated F(ab')2 mouse anti-human CD2, and
alkaline phosphatase-conjugated goat anti-mouse Ig were obtained
from Zymed Laboratories, Inc., South San Francisco, Ca.
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FITC-conjugated mouse Ig control, FITC-conjugated goat anti
mouse Ig, FITC-conjugated mouse anti-human HLA-DR, and PERCPconjugated mouse anti-human HLA-DR were obtained from Becton
Dickinson Immunocytometiy Systems, San Jose, Ca.
PE-conjugated mouse anti-human CD2 was obtained from AMAC
Inc., Westbrook, Me.
Anti-HIV-1 positive human serum was obtained from Boston
Biomedica, Inc., West Bridgewater, Ma.

2.3

Cell Culture
Cells were cultured (unless otherwise indicated) in complete

RPMI medium [RPMI-1640 (CellGro) supplemented with
100 U/ml penicillin (CellGro), 100 Mg/ml streptomycin sulfate (Fisher
Scientific), 2mM L-glutamine (CellGro), plus 10% fetal bovine serum
(HyClone)]. The cultures were placed in an incubator containing 5%
C02 at 37 °C.
Serum-free medium (CellGro) was used as indicated in the
production of several mAb to aid in the subsequent purification of mAb
from the supernatant.
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2.3.1 Coculture experiments using cell culture inserts
Cell cultures were performed at a final concentration of
106 cells/ml. Cells (0.25 ml) were added to the insert, and 0.25 ml
cells were added to each well of a 24-well plate. Addition of mitogens
and inhibitors, and the determination of metabolic activation or
proliferation were performed as described under “activation assays.”

2.4

Isolation of PBMC from Heparinized Whole Blood
Twenty milliliters fresh heparinized blood was diluted 1:2 in

RPMI-1640 medium, and carefully layered over 10 ml Ficoll-Hypaque
(Pharmacia) in a 50 ml conical tube. After 30 min centrifugation at
200 x g, the buffy coat was collected and washed twice by
recentrifugation in RPMI-1640 medium.

2.5

Purification of Antibodies

2.5.1 Protein A purification of IgG
The mAb supernatant was clarified by centrifugation (10,000 x g
for 10 min) and diluted 1:2 in phosphate-buffered saline (PBS), pH 8.0.
The solution was gravity-fed over a protein-A sepharose column (Pierce)
and washed with 3 volumes of PBS, pH 8.0, until absorbance at 280 nm
was less than 0.020. The mAb was then eluted in 5 volumes of 1 ml
citric acid, pH 3.0, and rapidly netralized with 50 pi 2.0 M Tris buffer,
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pH 8.0. Volumes containing sufficient protein, as measured by
absorbance at 280 nm, were pooled and dialyzed (membrane cutoff
10,000 daltons) against RPMI-1640 medium for 48 hr with several bath
changes.

2.5.2 Purification of IgM mAb by dialysis precipitation
IgM mAb supernatant was clarified by centrifugation (10,000 x g
for 10 min) and dialyzed (membrane cutoff 10,000 daltons) against a
running bath of deionized water for 24 hr. The supernatant was
collected and centrifuged at 15,000 x gfor 1 hr. The supernatant was
decanted, and the pellet was resuspended in RPMI-1640 medium.

2.5.3 E-Z-Sep purification of IgM mAb
IgM mAb supernatant from serum-free cell culture was purified
by E-Z-Sep IgM Partitioning (Middlesex Sciences, Foxborough, MA),
according to the product insert. Briefly, culture supernatant was added
to an equal volume of solution A, mixed gently for 30 min, centrifuged
for 30 min at 2000 x g, and then the supernatant was decanted. The
pellet was finally resuspended in solution B.
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2.6

Assay for Mitogenic Activation-Inhibition of PBMC.
Peripheral blood mononuclear cells (PBMC) were separated from

freshly drawn heparinized blood by centrifugation over Ficoll-Hypaque,
washed twice in RPMI-1640 medium, and resuspended in complete
RPMI medium. These cells were transferred to a microtiter tissue
culture plate at 2xl05 cells/well in a volume of 180 pi. Ten microliters
each of OKT3 (100 pg/ml), or RPMI-1640 medium as negative control,
were added to each well, in addition to 10 pi of spent culture
supernatant of anti-class II mAb, or RPMI-1640 medium as a negative
control. Each plate was incubated for 68 hr at 37°C. The cells in each
well were tested for proliferation and metabolic activity by 3H-thymidine
incorporation or the MTT method.

2.7

Cell Activation Assays

2.7.1 Thymidine incorporation assay
3H-Thymidine (ICN Radiochemicals) (50pCi/ml) was added to
each well of a microtiter plate (IpCi/well) on the third day after
mitogenic stimulation, and the cells were incubated for an additional
4 hr at 37°C. The cells were harvested on a glass filter paper with a
MASH cell harvester, and spots from each well were cut out and placed
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in 6ml vials with scintillation fluid. The vials were counted in a p
scintillation counter and automatically converted to decays per minute
(DPM). The DPM were plotted as a direct measure of DNA synthesis,
indicating lymphocyte activation.

2.7.2 MTT assay
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide
(MTT) (Pierce) from stock solution (5 mg/ml in Tris-buffered saline) was
added at a final concentration of 500 Mg/ml to each well of the culture
plate and the cells were incubated for 4 hr at 37°C. After incubation,
100 jh of 3% sodium dodecyl sulfate (SDS) in acidified (.04 N HC1)
isopropanol was added to each well, and mixed repeatedly (10 times by
multichannel pipette) to solubilize the formazan product. The plates
were read immediately with a microplate reader and the absorbance
(490 nm-650 nm) was plotted as a direct indicator of cellular activation.

2.7.3 MTS assay
In some experiments, the CellTiter 96AQueous Non-Radioactive
Cell Proliferation Assay (Promega, Madison, WI) was used in place of
MTT. The assay was used according to the product insert. Briefly,
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100 jul phenazine methosulfate solution was added to 2 ml MTS
solution. Twenty microliters of this solution was added to each well of
a 96-well plate containing cells to be assayed. The plates were read
after 3-4 hr with a microplate reader and the absorbance (490 nm650 nm) was plotted.

2.7.4 Combined MTS-thymidine or MTT-thymidine assay
Cells were cultured as for the single-determinant assay.
Thymidine was added as described for the thymidine incorporation
assay above, incubated for 16 hr, and then MTS was added. After 3 hr,
MTS cleavage was determined by absorbance reading, and then the
DNA was harvested to test for thymidine incorporation.

2.8

Protein Analysis

2.8.1 SDS-denatured polyacrylamide gel electrophoresis (PAGE)
Proteins were separated for analysis of size and purity, or prior to
western blotting, according to the method described in Current
Protocols in Immunology (CoWigan, 1992). Briefly, 10% polyacrylamideTris-Cl-SDS minigels (0.75 mm thick) were polymerized with TEMED
and ammonium persulfate. The gels were placed in running buffer, and
the samples in loading buffer containing bromophenol blue were
pipetted to each well. The gels were run at 10 mA constant current
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until the bromophenol blue reached the bottom of the gel. The gels
were removed from the apparatus and visualized by silver staining or
further processed for western blotting.

2.8.2 Silver staining of proteins in polyacrylamide gel
Polyacrylamide gels were stained for visualization of proteins
with Silver Stain (Bio-Rad, Richmond, Ca) according to the product
insert. Briefly, the gels were fixed first in 40% methanol-10% acetic
acid and then in 10% ethanol-5% acetic acid. The gels were then
oxidized 5 min, rinsed in deionized water, incubated with silver reagent
20 min, rinsed, and developed in three sequential developer baths until
bands appeared. Development was stopped in a final incubation with
5% acetic acid.

2.8.3 Western blot determination of anti-MHC class II mAb specificity.
The human B-lymphoblastoid cell line, Raji, was grown to
confluency in T25 cell culture flasks with complete RPMI medium.
After washing the cells twice in ice cold Tris-buffered saline, the
membrane proteins were extracted by resuspending the cells at
108 cells/ml in Triton X-100 lysis buffer (300 mM NaCl, 50 mM TRIS-C1,
pH 7.6, 0.5% Triton X-100) containing protease inhibitors (10 (ig/ml
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leupeptin, 10 pg/ml aprotinin, ImM phenylmethylsulfonyl fluoride, and
1.8 Mg/ml iodacetamide). The suspension was lightly vortexed every
5 minutes during incubation for 45 minutes at 4°C. The suspension
was then centrifuged at 10,000 x gfor 15 min to precipitate the nuclear
fraction. The supernatant was collected and saved for SDS-PAGE
separation. Cellular proteins and a molecular weight standard
(1 mg/lane) were separated by SDS-PAGE on a 16 cm-wide gel.
Proteins were transferred to nitrocellulose by overnight electrophoresis
at 14 V. The position of the proteins in the molecular weight standard
were visualized by Ponceau S solution and marked with indelible ink.
The sheet was then destained and probed with the anti-class II mAh.
The sheets were then incubated with a horseradish peroxidase-labeled
anti-mouse secondary mAb. Bound antibody was visualized by
incubation in the substrate nitroblue tetrazolium-5-bromo-4-chloro-3indolyl phosphate until bands appeared. Molecular weights of the
detected proteins were determined by comparison with the standard
ladder, and compared with positive controls to confirm their identity.
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2.9

Flow Cytometry

2.9.1 Flow cytometry for analysis of membrane protein expression
Cells were harvested from culture by gentle aspiration,
transferred to microtubes, and washed twice in PBS with NaNs, pH 7.0.
After final aspiration of supernatant, the cells were resuspended and
either 10 pi of stock fluorescent-labeled antibody or 100^1 culture
supernatant was added to the cells. The cells treated with culture
supernatant were then labeled with FITC-labeled goat-anti-mouse
secondary mAb. The cells were incubated for 30 min, washed once, and
then resuspended in PBS. Gating and cytometer settings were
determined from unstained controls. Side scatter, forward scatter, and
fluorescence were determined by FACScan (Becton-Dickinson).

2.9.2 Flow cytometry to quantitate T cell apoptosis from PBMC cultures
Cells were labeled with FITC-labeled anti-CD2 mAb as for
membrane expression above. Immediately before analyzing the cells,
1 |ig/ml ethidium bromide (Ipl stock saturated solution) was added.
Cells were gated first into CD2+/CD2 , and then analyzed for forward
scatter and ethidium bromide staining.
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2.10 Fluorescent Microscopy
PBMC were cultured in 4-well slide culture vessels (Nunc) as for
experiments in 96-well plates. Ethidium bromide (1 fig/ml) and 1 [ig/ml
acridine orange were added at 24 hr. The plates were centrifuged
lightly at 100 x g for 5 min, and supernatant was aspirated. The wells
and rubber seals were removed, a cover slip placed, and the fluorescent
cells were visualized under ultraviolet illumination.

CHAPTER 3
RESULTS
In previous work conducted in this laboratory (Molinaro, personal
communication) it had been noted that mAb 417 was able to inhibit
ConA T cell activation, but unlike other mAb to class II molecules, was
not able to inhibit OKT3-mediated T cell activation. This observation
raised doubts about the current model of T cell inactivation by anti
class II mAb, and prompted this work.

3.1

Specificity of mAbs Q5/13 and 417
Class II molecule specificity of mAbs 417 and Q5/13 was

determined by testing them on the cell lines Raji and RJ2.2.5, which
are class II molecule positive and negative, respectively. First, class II
molecule expression by these two cell lines was determined by using a
commercial mAb to HLA-DR in a flow cytometric analysis. Raji showed
high expression of HLA-DR (Figure 1), and RJ2.2.5 showed a small
population of cells expressing small amounts of HLA-DR. This lowlevel expression is consistent with reports that revertants may occur
in this cell line (Rigaud et al., 1994). Notably, RJ2.2.5 does express a
high level of the class I protein p2-microglobulin (Figure 1),
demonstrating the specificity of the class II molecule deficiency in this
33
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cell line. Neither cell line showed significant binding of the control
antibodies.
To avoid the non-specific activity of various cytokines present in
culture supernatants, mAbs 417, Q5/13, and OKT3 were first purified.
Q5/13 and OKT3, which are IgG2a, were purified by protein-A affinity
chromatography. mAb 417, an IgM, was purified by either dialysis
precipitation from supernatant of cultures grown in complete RPMI, or
by using the E-Z-Sep purification system for supernatant of cultures
grown in serum-free medium. The protein-A and E-Z-Sep purified mAb
were then tested by PAGE (Figure 2). Electrophoresis of mAb 417
revealed bands of 78 kd (|i heavy chain), and 25 kd (light chain). Q5/13
had bands of 55 kd (y2 heavy chain), 52 kd (yl heavy chain), and 25 kd
(light chain). The yl chain in Q5/13 may have come from the
hybridoma fusion partner, P3X63Ag8, the cell line used for creating
Q5/13. OKT3 had the expected bands at 55 kd and 25 kd corresponding
to the y2b Ig subclass.
The Raji and RJ2.2.5 cell lines were then used to verify the
specificity of mAb 417 and Q5/13. Raji and RJ2.2.5 cell lines were first
treated with Q5/ 13 or 417 (or their isotype controls OKT3 or 718,
respectively) as the primary antibody, then treated with a FITC-labeled
goat-anti-mouse secondary antibody, and then analyzed for
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fluorescence by flow cytometry. Binding of Q5/13 to Raji cells was
30-fold higher than binding to RJ2.2.5 cells, and 100-fold higher than
the isotype control (Figure 3). Binding of 417 to Raji cells was
significantly lower than Q5/13 (Figure 4), indicating that 417 may have
lower affinity than Q5/ 13. The low affinity of 417 is consistent with
preliminary data obtained in this laboratory (Dr. G.A. Molinaro,
personal communication) using a radioimmunoassay and a resetting
assay. Nonetheless, 417 still bound to Raji cells 8-fold more than to
RJ2.2.5 cells, and binding to RJ2.2.5 was not significantly greater than
background staining of the isotype control mAb (Figure 4). These
results indicated that 417 and Q5/13 are specific for the MHC class II
family of cell surface proteins.
To further determine the subclass specificity of 417 and Q5/13,
417 and Q5/13 were tested for reactivity with proteins from the Raji
cell line by a western blotting assay. Both anti-class II mAb reacted
with five distinct bands ranging from 26-30 kD (Figure 5). Since MHC
class II p-chains range in size from 26-29 kd (Collins et al., 1991), and
Raji has the haplotypes DR3/DRwlO, DQwl/DQw2, DP4/DP4 (Soos
and Johnson, 1994), these 5 bands correspond to the p chains of class
II molecules. Thus, Q5/13 was confirmed to be specific for a
monomorphic epitope of the p chains of MHC class II molecules, as
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Figure 3. Reactivity of mAb Q5/13 with native cell-surface class II
molecules.
MAb Q5/ 13 was tested for binding to Raji and RJ2.2.5
cell lines by flow cytometry. Cells lines in log-phase growth were
labeled with mAb Q5/13 or isotype control (OKT3) followed by FITCconjugated goat anti-mouse Ig. Cell fluorescence was measured by
flowr cytometry, and ungated fluorescence histograms of 104 cells
plotted for each experimental condition, mf - mean fluorescence.
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Figure 4. Cell specificity of mAb 417 for native cell-surface epitopes.
MAb 417 was tested for binding to Raji and RJ2.2.5 cell lines by flow
cytometry. Cells lines in log-phase growth were labeled with mAb 417
or isotype control (718) followed by FITC-conjugated goat anti-mouse Ig.
Cell fluorescence was measured by flow cytometry, and ungated
fluorescence histograms of 104 cells plotted for each experimental
condition, mf - mean fluorescence.
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previously shown (Akiyama, 1985). Mab 417 was shown to also have
specificity for a monomorphic epitope of the p chain of HLA-DP, -DQ,
and -DR.
These findings rule out that the inability of 417 to inhibit the
OKT3 activation of T cells is due to a specificity, different from that of
Q5/13, for a subclass of class II molecules having a different role in
immune regulation.

3.2

Inhibition of T Cell Mitogenesis by Anti-Class II mAb
To confirm and expand on the original data of Molinaro, PBMC

were treated with different activators and with 417 or Q5/13 and then
tested for thymidine incorporation. As expected, Q5/13 inhibited the
tested activators (Figure 6). mAb 417 inhibited ConA-dependent T cell
activation by >95%, but somewhat enhanced OKT3-dependent
activation.

3.3

Activation of APC During the Inhibition of OKT3-

Mediated T Cell Mitogenesis by Anti-Class II mAb
In an attempt to avoid the costly and environmentally hazardous
3H-thymidine assay, the MTT assay was developed for use in the
proliferation experiments. This assay measures the activity of
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Figure 6. Inhibition of T cell activations by mAb to HLA-DR: OKT3dependent activation is inhibited by Q5/13 but not 417.
MAbs 417
and Q5/13 were tested for their ability to inhibit T cell activation as
measured by 3H-thymidine incorporation. PBMC were activated by
OKT3 (3 ng/ml, triangles), ConA (1 pg/ml, squares), SEA (1 ng/ml,
diamonds), or MLR (circles). 417 purified by dialysis precipitation and
protein A-purified Q5/13 was used for ConA and OKT3 inhibition
experiments. Spent culture supernatant was used for MLR and SEA
inhibition experiments. MAb concentration in supernatant was
estimated to be 10 jig/ml based on activity in other experiments.
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mitochondrial dehydrogenase, which has been shown to correlate with
the cell number for any given cell population (Loveland et aL, 1992).
However, when the MTT assay was used in place of the 3H-thymidine
incorporation assay to measure anti-class II mAh inhibition of T cell
proliferation, inhibition was not seen.
To confirm this unexpected disparity between the two assays, the
MTT assay was combined with the 3H-thymidine incorporation assay in
the same experiment, and performed sequentially on the same cell
population in one single assay. This novel two-in-one assay was first
validated by using a cell line in log phase or OKT3-stimulated PBMC.
There was excellent correlation between MTT and 3H-thymidine assays
provided that 3H-thymidine incorporation was concluded before adding
MTT to the culture media. Addition of MTT at the same time or before
the addition of 3H-thymidine completely abrogated thymidine
incorporation (data not shown). After the validation, this method for
measuring mitochondrial dehydrogenase activity and cell proliferation
within the same cell population was used on PBMC treated with OKT3,
Q5/13, or both mAb (Figure 7). Q5/13 alone enhanced the cleavage of
MTT substrate while a control mAb did not (Figure 7A). However, this
increase in metabolic activity occurred in the absence of any
3H-thymidine incorporation (Figure 7B), indicating that the increased
cleavage of MTT was not due to increased cell numbers, but rather to
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Figure 7. Mitochondrial enzyme activity (A), compared with DNA
synthesis (B) and inhibition of T cell mitogenesis (C) of PBMC treated
with Q5/13.
PBMC were cultured with various concentrations of mAb
Q5/13 alone (squares), x63 control (triangles), or Q5/13 in the
presence of 25 ng/ml OKT3 (circles). After 72 hours, metabolic activity
and cell proliferation were tested by the MTT assay (open symbols,
Absorbance) and 3H-thymidine incorporation assays (closed symbols,
DPM), respectively.
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increased enzyme activity or increased enzyme expression. Finally, the
dose response curve for enhanced metabolic activity by Q5/13 alone
closely mirrored the dose response curve of Q5/13 inhibition of T cell
proliferation (Figure 7C). Notably, the half-maximal concentrations of
Q5/13 were comparable in the two curves. This finding indicated that
the population of MHC class II molecule+ cells had been stimulated,
raising the novel possibility that the inhibition of OKT3-mediated T cell
mitogenesis may be an active phenomenon mediated by the MHC class
II molecule positive cells rather than a passive phenomenon mediated
by steric hindrance of the interaction between T cells and APC.
To further characterize the relationship of metabolic activation to
inhibition of T cell proliferation, a panel of anti-class II mAb known to
be inhibitory to lectin-, superantigen-, or OKT3-mediated proliferation
were tested for metabolic activation by the MTT assay (Figure 8). All of
the inhibitory mAb were able to induce metabolic activation of PBMC
when used alone. In contrast, mAb 417, which inhibits lectin- and
superantigen-, but not OKT3-mediated proliferation, did not induce
metabolic activation. These data indicated that metabolic activation is
required for the inhibition of OKT3-mediated T cell proliferation, but
not for the inhibition of lectin or superantigen-mediated proliferation.
To compare the kinetics of this novel anti-class II mAbdependent activation with the conventional OKT3-dependent
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activation, PBMC were cultured with Q5/13 and with OKT3, and then
tested by the MTT assay at several times (2, 3, 4, 8, 24, 48, and
72 hours). Q5/13 and OKT3 showed veiy similar linear increases in
mitochondrial enzyme activity (Figure 9), but for different reasons. The
increase mediated by OKT3 was merely due to increased cell numbers,
as indicated by proliferation, while the increase mediated by Q5/13
occurred in the absence of proliferation. Therefore, the basal level of
cellular metabolism seems to be increased only in the Q5/13stimulated cells. The control antibody and mAb 417 did not increase
the mitochondrial activity at any time. In all cultures, including
controls, the absorbance decreased to a stable baseline over the first
6 hours, probably because of the phenol red in the culture media,
which at basic pH interfered in the absorption measurements until the
CO2 in the medium equilibrated with the CO2 of the incubator
atmosphere.
To further rule out the model of steric inhibition in Q5/ 13
inhibition of OKT3 T cell activation, other kinetic studies were done in
which Q5/13 was added as an inhibitor to T cell mitogenesis at various
times before and after addition of the mitogen. It was hypothesized
that if competitive binding of the anti-class II mAb was the mechanism
for inhibition, preincubation with the anti-class II mAb would show
maximum inhibition while preincubation with the mitogen would result
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in decreased inhibition. Mab 417 and Q5/13 were found to have
identical time-courses with respect to inhibition of ConA activation,
with a complete loss of inhibition immediately distal to addition of the
mitogen (Figure 10), suggestive of a steric mechanism. At
approximately two hours, inhibition returned to near-maximal levels,
possibly corresponding with cycling and novel expression of MHC
receptors which could then bind the anti-class II mAb. The kinetics of
inhibition by OKT3, however, do not indicate a refractory period. In
this case, inhibition is relatively even throughout the times tested,
with maximum inhibition occurring when anti-class II mAb was added
immediately before or simultaneous with the addition of mitogen.
Some gradual loss of inhibition was seen throughout the next 2 hours,
at which time inhibition had reduced to approximately 50%.
Thus, although Q5/13 and 417 were both reactive with class II
molecules, Q5/13 was able to metabolically activate PBMC, but 417
was not. To understand where the transduction of the 417 signal had
been blocked, mAb 417 and Q5/13 were tested for the ability to induce
a very early event of signal transduction, that is tyrosine
phosphorylation, in Raji and RJ2.2.5 cells. Q5/13 induced tyrosine
phosphorylation of 12 substrates in Raji, but 417 and 718, an anti-IgM
mAb, did not (Figure 11). Moreover, Q5/ 13 did not activate RJ2.2.5, a
class II molecule-negative mutant of Raji. Thus, it seems that Q5/13
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induces tyrosine phosphorylation in B cells by ligation of class II
molecules, and 417 is unable to induce this signal.
The reason behind 417's inability to provide this inhibitory signal
was then investigated. To determine if mAb 417 is unable to inhibit
OKT3-induced mitogenesis because of its IgM isotype, a panel of other
IgM anti-class II mAb were tested for their ability to inhibit T cell
proliferation (Figure 12). All of the IgM mAb tested were able to block
lectin-, superantigen-, and OKT3-mediated T cell proliferation. Thus,
the inhibition profile of 417 (blocking lectin- or superantigen- but not
OKT3-mediated T cell proliferation) can not be attributed to its IgM
isotype.

3.4

Monocytes Mediate the Metabolic Activation and the

Mitogenic Inhibition Induced by Q5/13
The simultaneous presence of metabolic activation and mitogenic
inhibition, both induced by Q5/13, suggested that two distinct cell
populations were most likely responsible for mediating these opposing
effects. Nevertheless, since resting T cells, which are class II
molecule negative, express class II molecules when activated by OKT3,
there was the possibility that Q5/13 might have acted directly on the
activated T cells.
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Figure 12. Inhibition of T cell mitogenesis by other IgM anti-class II
mAb.
A panel of IgM anti-class II mAb obtained courtesy of Saldano
Ferrone, MD, for their ability to inhibit T cell proliferation induced by
various mitogens. Freshly isolated PBMC were cultured with anti-class
II mAb (final concentration - 1:10 dilution of spent supernatant) alone
or in the presence ConA (3 ng/ml), PHA (3 Mg/ml), SEA (1 ng/ml), or
OKT3 (1 Mg/ml).

65

100000

10000

■ Control
^ KS5
Q

KSll
□ AC 1.59

1000

100
None

ConA

PHA

Mitogen

SEA

OKT3

66

To test if T cells express sufficient class II molecules during a
typical 3-day proliferation assay to be directly affected by anti-class II
mAb, expression of the HLA-DR on T cells following OKT3 stimulation
of PBMC was followed by flow cytometry for 6 days (Figure 13). A small
minority of freshly isolated T cells showed minimal HLA-DR expression
in freshly isolated PBMC (less than 5% above background staining).
Following OKT3 stimulation, the expression of MHC class II molecules,
as determined by mean fluorescence, decreased slightly over the first
four days (Figure 13, panels b through e), with a subsequent increase
in expression over the 5th and 6th day to a final level approximately
twice that of the freshly isolated cells (Figure 12g). This level of
expression, however, was only 7% of the constitutive expression of
resting B cells from freshly isolated PBMC (Figure 12a). Thus, a direct
inhibitory effect of anti-class II mAb on T cells is not likely, due to
their lack of class II molecule expression during the typical three-day
mitogenesis assay.
To test if B cells may be responsible for the increase in metabolic
activity seen in Q5/13-treated PBMC, a panel of B cell lines were
cultured for three days in the presence of Q5/13 and tested for
enhanced mitochondrial enzyme activity by the MTS assay (Figure 14).
All nine B cell lines showed some decrease in mitochondrial
dehydrogenase activity, as did the T cell line Jurkat. The cell lines
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UCNS, Wil, 4098, 2132, and Daudi were inhibited at least 30%. Thus,
B cells are not likely to be the cells responsible for the increase in MTT
cleavage observed in anti-class II mAb-treated PBMC.
To test if adherent monocytes from the PBMC cultures were
responsible for the increased metabolic activity, non-adherent cells
were separated from adherent cells on the third day of culture, and
both cell populations were tested for mitochondrial dehydrogenase
activity by the MTS assay (Figure 15). Non-adherent cells from OKT3stimulated PBMC (Figure 15, panel A, open diamonds) showed a dose
response curve to Q5/13 of decreased metabolic activity that paralleled
the inhibition seen by thymidine incorporation (Figure 7C). In
contrast, the adherent cells (closed diamonds) showed a marked
increase in metabolic activity that was inversely related to the non
adherent cells. When PBMC were treated with Q5/13 alone (Figure 15,
panel B), all of the increase in metabolic activity previously described
(Figure 7A) could be attributed to the adherent cell population. Thus,
metabolic activation in PBMC cultures treated with anti-class II mAb
can be attributed entirely to the adherent monocyte population, and
this monocyte activation shows strong correlation with the inhibition
of non-adherent cells.
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Figure 15. Mitochondrial enzyme activity in adherent and non
adherent populations,
Adherent and non-adherent cells from PBMC
cultured with various concentrations of purified mAh Q5/13, with or
without OKT3 (10 ng/ml), were tested for metabolic activity. After
three days, non-adherent cells were gently resuspended and
transferred to a new plate. Fresh RPMI was added to adherent cells,
and metabolic activity was determined for both cell populations by the
MTS assay.
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3.5

Inhibition of OKT3-Mediated T cell Proliferation is

Mediated by a Soluble Factor
To determine if the inhibition of T cell proliferation by anti-class
II mAb activated monocytes was mediated by a soluble factor, tissue
culture inserts with a permeable membrane were used to test whether
Q5/13-treated PBMC could inhibit the activation of OKT3-treated
PBMC across the membrane (Figure 16). When the PBMC in the
inserts were treated with solid phase Q5/13, the OKT3-treated cells in
the wells showed more than 50% inhibition of MTT cleavage (Figure 16
open circles) when compared with OKT3-treated cells cocultured with
mock treated PBMC in the insert. In a similar experiment, the Q5/13treated cells also inhibited 3H-thymidine incorporation of the OKT3treated cells (Figure 16, solid circles). Solid phase Q5/13 without
PBMC in the inserts did not inhibit mitogenesis in the wells (data not
shown), ruling out spontaneous antibody leakage from the sepharose
beads. Cell-dependent leakage of antibody from the sepharose
(resulting from the possible release of proteolytic enzymes from
macrophages) was also ruled out since MTT cleavage was inhibited in
parallel with thymidine incorporation, not enhanced as in the
experiment of Figure 7C. Thus, it seems that cells can be signaled
through class II molecules to release a soluble cytokine that
downregulates T cells.
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Figure 16. Inhibition of T cell mitogenesis across a membrane.
Tissue culture inserts were used to test whether PBMC treated with
solid-phase Q5/13 could inhibit the activation of OKT3-treated PBMC
across a membrane (0.4^m pore size). Sepharose-conjugated Q5/13
was added to PBMC in the inserts, while PBMC in the wells were
treated with soluble OKT3 (10 ng/ml). After three days, inserts were
removed and metabolic activity and proliferation were determined for
PBMC in the wells.
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In a similar experiment, adherent monocytes from PBMC were
pretreated with various amounts of Q5/13 and washed before the
addition of fresh PBMC and OKT3. The Q5/13-treated monocytes were
able to inhibit mitogenesis by over 80% (Figure 17), despite the
addition of fresh monocytes and B cells in much greater quantities
(adherent monocytes vs. total monocytes and B cells). Thus the
soluble inhibitory factor demonstrated in Figure 16 appears to be
released by adherent monocytes, and this inhibitory factor appears to
be dominant over the normally proliferative functions of fresh APC.

3.6

Inhibition of T cell Proliferation by Anti-Class II mAb

Causes Activation-Induced Apoptosis
To assess whether the Q5/13 inhibition of OKT3 activation was
due to cell death rather than anergy, PBMC were treated with Q5/13
and OKT3, and their DNA was tested for nucleosomic fragmentation by
agarose gel electrophoresis (Figure 18). The double treated PBMC
(lane 6) showed greater DNA fragmentation than the PBMC treated
with Q5/13 (lane 2) or OKT3 alone (lane 5). A similar increase in DNA
fragmentation was found in PBMC treated with Q5/13 and ConA
(lane 4), as compared with Q5/13 (lane 2) or ConA alone (lane 3).
Significantly, this DNA fragmentation occurred in T cells isolated from
double treated PBMC (lane 8). In addition, this Q5/113-mediated
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apoptosis was dose dependent (Figure 19). Thus, Q5/13 enhanced the
apoptosis of T cells in PBMC treated with OKT3 or ConA. The degree of
apoptosis of double treated PBMC (Figure 18) was comparable to the
apoptosis induced by 600 rads y-irradiation (Figure 32, lane 8). Since
600 rads y-irradiation will typically induce apoptosis in 90-100% of
peripheral T cells (Duke and Cohen, 1992), it seems the majority of the
cells in this experiment had undergone apoptosis. Thus, it seems that
the stimulation of APC via class II molecules was an activation signal
for APC to release a cytokine that was particularly apoptotic for
activated T cells.

3.7

Conventional Microscope Analysis of PBMC Stimulated

with Mitogen and Anti-Class II mAh
It is known that B cells aggregate when treated with anti-class II
mAh (Ramirez et al., 1992), and that PBMC also aggregate when
stimulated with mitogen. Both aggregations are believed to be
mediated by cell adhesion molecules that have been upregulated during
cell activation (Wagner et al., 1993).
To see if the inhibition of mitogenesis by anti-class II mAb was
associated with inhibition of OKT3-mediated aggregation, PBMC were
cultured for 24 hours with OKT3, Q5/13, or both. As anticipated,
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Figure 19. Titration of anti-class II mAb-induced activation-dependent
apoptosis.
PBMC were tested for apoptosis following treatment with
anti-class II mAb and mitogen. PBMC were cultured with lOng/ml
OKT3 and increasing amounts of mAb Q5/13. After 24 hours, cells
were resuspended, and fragmented DNA was purified from
chromosomal DNA by affinity chromatography and separated by
electrophoresis in horizontal agarose gels (1.5%). Q5/13 (pi
supernatant/ml cell culture): lane 1 - control (x63, 100 pi), lane 2-10
pi, lane 3-50 pi, lane 4 - 200 pi.
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Figure 20. Culture morphology of PBMC cultured with Q5/13 and/or
OKT3.
PBMC were cultured in 24-well plates (106 cells/well in 1 ml
complete RPMI) with control mAh (x63), Q5/13 (10 ng/ml), OKT3 (10
ng/ml)> or both Q5/13 and OKT3. After overnight incubation, cultures
were photographed with Kodak T-Max 100 film using phase-contrast
microscopy in an inverted microscope with 50x dry objective.
Approximate scale: 1 cm = 200 (Lim.
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Figure 21. Aggregation of PBMC cultured with Q5/13 and/or OKT3 for
6 hours.
PBMC were cultured in 4-chambered culture slides
(106 cells/well in 1 ml complete RPMI) with control mAh (x63), Q5/13
(lOjiig/ml), OKT3 (10 ng/ml), or both Q5/13 and OKT3. After 6 hours,
cultures were stained with ethidium bromide and acridine orange for 5
minutes and centrifuged. After gentle aspiration of the supernatant,
the chambers were removed from the slide and coverslips mounted.
Cells were photographed with Kodak Gold-100 film under 40x oil
objective using fluorescent microscopy. Approximate scale: 1 cm = 250
pm.

Control

Q5/13

OKT3

Q5/13 + OKT3
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Figure 22. Formation of multinucleated giant cells from PBMC
cultured with Q5/13 and OKT3 for 24 hours.
PBMC were cultured in
4-chambered culture slides as in Figure 21. After 24 hours, cultures
were stained with ethidium bromide and acridine orange for 5 minutes
and centrifuged. After gentle aspiration of the supernatant, the
chambers were removed from the slide and coverslips mounted. Cells
were photographed with Kodak Gold-100 film under lOOx oil objective
using fluorescent microscopy. A-Q5/13only. B - Q5/13 and OKT3.
Arrows - recently phagocytosed cells which still show cytoplasmic
staining distinct from nuclear staining. Approximate scale: 1 cm =
100 |im.

A

B
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The diameter of these giant cells, when measured in a hemocytometer,
ranged from 50 nm to more than 200 nm. Following centrifugation, the
flattened giant cells were roughly 500 nm, using free individual
lymphocytes as a 10-12nm gauge, and contained as many as 150 nuclei
each.

3.9

Flow cytometry analysis of apoptosi s
PBMC cultured for 24 hours with Q5/13, OKT3, or both were

analyzed for side scattering and forward scattering. No difference was
seen in cultures treated with Q5/13 alone when compared with
untreated cultures (Figure 23A and 23B). In cultures treated with
OKT3, the lymphocyte population formed a "tail" corresponding to an
increased size (forward scatter) of the activated, dividing T cells
(Figure 23C). In cultures treated with both OKT3 and Q5/13, this tail
was gone, but unexpectedly, the monocyte population was also missing
(Figure 23D). In addition, the expected shift in side and forward
scatter of lymphocytes undergoing apoptosis was not seen. Thus, it
appears that the formation of multinucleated giant cells in doubletreated PBMC, as seen by fluorescent microscopy, is related to the
"disappearance" of the monocyte population normally seen in flow
cytometry.
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Figure 23. Loss of macrophages visible by flow cytometry in PBMC
cultured with Q5/13 and OKT3.
PBMC were evaluated for changes in
side scatter and forward scatter characteristics by flow cytometry
following treatment with anti-class II mAb and OKT3. PBMC were
cultured as in Figure 21. After 24 hours, cells were resuspended by
repeated aspiration, and adherent cells were removed by incubation
with trypsin/EDTA. Visual examination of the culture plate indicated
complete recovery of cells. Adherent and non-adherent cells were
pooled, and forward scatter and side scatter data were collected for
105 cells. 3D histograms are shown with X axis (origin to upper right)
indicating granularity, Y axis (origin to lower right) indicating relative
size, and Z axis (vertical) indicating events per channel. A = Control
(100 pi x63), B = Q5/13 (10 pg/ml), C = OKT3 (10 ng/ml), D = OKT3 and
Q51/3.
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Double-treated PBMC were also tested by a flow cytometric
method to identify and quantitate apoptotic cells. This method uses
ethidium bromide to stain apoptotic cells which have already lost their
membrane integrity, combined with a decrease in forward scatter
typically seen in apoptotic populations related to cell shrinkage. As
described previously, in almost all the experiments there was loss of
the monocyte population (Figure 23) but no detectable apoptosis in the
T lymphocyte population (Figure 24). However, in two experiments, the
monocytes did not form giant cells, for unknown reasons (Figure 25D).
Significantly, the lymphocyte population in these two experiments
showed a dramatic shift in side scatter, forward scatter, and ethidium
bromide staining (Figures 25D and 26D) which are typical of apoptosis
and are due to cell shrinkage, chromatin condensation, and loss of
membrane integrity, respectively. Moreover, the degree of apoptosis
was dose-dependent with respect to both Q5/13 and OKT3 (Figure 27),
indicating that the activation of both monocytes and lymphocytes are
needed for the induction of T cell apoptosis.

3.10 IgG From an AIDS Patient May Mimic Anti-Class II mAb
To evaluate whether anti-gpl20 antibodies, which can cross-react
with MHC class II molecules, may mimic anti-class II mAb, IgG was
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Figure 24. Apoptosis quantitation by flow cytometry following 24-hr
culture with OKT3 and/or Q5/13: Cultures in which giant cell
formation occurs. T cells were evaluated for apoptotic changes by flow
cytometry following culture of PBMC with anti-class II mAb and OKT3.
PBMC were cultured as in Figure 21. After 24 hours, cells were
resuspended, washed, and labeled with CD2-FITC. Cells were stained
with ethidium bromide 5 minutes before flow cytometric analysis. After
collecting 104 events, T cells were gated by side scatter, forward
scatter, and CD2 (green) fluorescence. Gated cells were analyzed for
size and ethidium bromide (red) fluorescence. 3D histograms are
shown with X axis (origin to upper right) indicating ethidium bromide
fluorescence, Y axis (origin to lower right) indicating relative size, and
Z axis (vertical) indicating events per channel. A = Control (100 pi x63),
B = Q5/13 (10 pg/ml), C = OKT3 (10 ng/ml), D = OKT3 and Q51/3.
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Figure 25. Shift in lymphocyte population typical of apoptosis, and
lack of giant cell formation in PBMC cultured with Q5/13 and OKT3.
PBMC were evaluated for changes in side scatter and forward scatter
characteristics by flow cytometry following treatment with anti-class II
mAh and OKT3. PBMC were cultured as in Figure 21. After 24 hours,
cells were resuspended by repeated aspiration. Forward scatter and
side scatter data were collected for 104 cells. 2D dotplots are shown.
A = Control (100 pi x63), B = Q5/13 (10 pg/ml), C = OKT3 (10 ng/ml),
D = OKT3 and Q51/3.
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Figure 26. Apoptosis quantitation by flow cytometry following 24-hr
culture with OKT3 and/or Q5/ 13: Cultures in which giant cell
formation does not occur,
T cells were evaluated for apoptotic
changes by flow cytometry following culture of PBMC with anti-class II
mAb and OKT3. PBMC were cultured as in Figure 21. After 24 hours,
cells were resuspended, washed, and labeled with CD2-FITC. Cells
were stained with ethidium bromide 5 minutes before flow cytometric
analysis. After collecting 104 events, T cells were gated by side scatter,
forward scatter, and CD2 (green) fluorescence. Gated cells were
analyzed for size and ethidium bromide (red) fluorescence. 3D
histograms are shown with X axis (origin to upper right) indicating
ethidium bromide fluorescence, Y axis (origin to lower right) indicating
relative size, and Z axis (vertical) indicating events per channel.
A - x63 (100 jil/ml), B - Q5/13 (10 pg/ml), C - OKT3 (10 ng/ml) + x63,
D - OKT3 + Q5/13.

102
C/D

<u
GO

o.g

1—H

Oh C/3
o
^ ^ if Q ^
.5 ,0 o CN O
w ^ 3 d o
>
^
ii p- s

o S 3^

xO
o^

x o 0 o g:
a 2; o c 9
S I ^ P C
j- y 2 ■£ xi

C 2 CQ ««
^ CQ ft. 73 ~
CO
CO

Oh

• « «

PIS

o

+J

d.

^ i2 J5

o c O?^
^ -o^ c! HCJ rC^
^

d

cd ^

j-j

qj 4-J ro

73 0

u .o

' co '5b

o 2

o ^

^c ^<- S> ad WD°
2 c^ Ot^ ^C
^
cd
•»

h—H

^

c

flj ^

> = 2 o n
'+j
^

CO 5 2
CO -M <P

O
CJ

'O

^

^

^ »—H
cb QJ
$ ^ ctf
vO

B■£

ti

"2
E
<C

^ 5 3 »
= = £ "S
13 £
cd
g'T.B i
<L> r? ^ Eh

•S

^60 S

+3

P C P cd

« 60 t 52 (o
^ o <U ^ ^

t; •= e ■« «

•N°

c ^ O^ cd0
< 2^^
^ ^ 5
. +J ^ 0

§§ §g•
is u
'Ig ^
3

l> d co ^r d 2
CS qj ‘d ^3 -0 ^
flj -or; n
O P
5-h 'P
-hh ^
q

S:
c<D O^h rv
cd +^j +2j
73
5b a o 5T o c

■'r-T (D
Cih -d

Oh
tH-H
cd Oh O

o
o

103

104
purified from the serum of an AIDS patient by affinity chromatography
on a protein-A column. When tested on PBMC isolated from a normal
individual, the isolated HIV-IgG inhibited OKT3 mitogenesis and
enhanced mitochondrial enzyme activity (Figure 28). The two dose
response curves were similar to the curves obtained with anti-class II
mAb in the previous experiments. The final Ig concentrations used in
these experiments were less than or equal to physiologic
concentrations of the original serum sample.
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CHAPTER 4
DISCUSSION
Two complementary sets of experiments concerning inhibition of
T cell proliferation by anti-class II antibodies are described herein.
One set concerns the characterization of an anti-class II mAb that is
able to inhibit MHC-dependent T cell mitogenesis (i.e., lectin,
superantigen, or mixed lymphocyte culture) but not MHC-independent
T cell mitogenesis (i.e., OKT3). PBMC, B cell lines, and adherent
monocytes show no evidence of activation by this mAb. In contrast,
the second set of experiments shows that MHC-independent T cell
mitogenesis is inhibited only by mAb that also show evidence of APC
activation. These findings indicate not only a difference between the
two types of anti-class II mAb, but imply a major difference between
the mechanisms of activation (and therefore inhibition) of the two
classes of activators.
In this manuscript I also describe the finding that ligation of
class II molecules may lead to significant upregulation of mitochondrial
enzyme activity in cells that are not proliferating. While the fact
seems obvious that some types of activation may be metabolic rather
than proliferative, this finding appears to be novel on several levels.
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Finally, activation of APC by anti-class II mAb is shown herein to
result in the release of a soluble factor that is inhibitory to T cell
proliferation, and leads to apoptosis of these T cells and phagocytosis
by monocytes.
The following discussion will address these findings on the basis
of differences between the MTT and 3H-thymidine assays, differences
between the two types of mitogens, differences between the two types
of anti-class II mAb, and the role that class II molecule ligation may
play in physiologic and pathologic immune responses.

4.1

Cell Activations Without Proliferation May Be Revealed

by the Combined Use of MTT and 3H-Thymidine
The MTT colorimetric assay has been proposed as a replacement
for the 3H-thymidine incorporation assay despite the fact that the two
assays are measures of different cellular properties (mitochondrial
dehydrogenase activity and proliferation, respectively). This has been
possible because most cells express mitochondrial dehydrogenase at a
constant level, and thus the correlation between cell number and MTT
cleavage has been demonstrated in many systems and cell types
(Loveland et al., 1992). However, in principle the MTT assay could also
reveal cell activations that are independent of cell division if they
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resulted in increased expression or activity of the relevant
mitochondrial enzymes.
Density-purified human PBMC were stimulated with mitogens
(ConA, SEA, and OKT3), and with a mitogen inhibitor (mAh Q5/13, a
monoclonal antibody to HLA-DP, -DQ, -DR). In this system, there was
good correlation between the MTT and 3H-Thymidine incorporation
assays when the cells were treated with mitogen alone. However, with
the addition of mAb Q5/13, the 3H-thymidine incorporation decreased
as expected, while MTT cleavage increased unexpectedly. Moreover,
when PBMC were treated with mAb Q5/ 13 alone, the MTT assay
showed marked metabolic activation in the absence of any increase in
3H-thymidine incorporation. Notably, the metabolic activation by mAb
Q5/13 was at a level equivalent to that induced by mitogenic
proliferation. The fact that this high level of metabolic activity is
restricted to the adherent monocyte population, which accounts for
only 10-15% of the cells in PBMC, makes this metabolic activation all
the more impressive.
These data indicate that the combined use of these two assays
may provide additional information in systems when cell activation may
not be followed by proliferation. This dissociation between activation
and proliferation within a single cell type may prevent the interchange
of the assays in homogenous cell systems. In addition, in

110
heterogeneous cell systems in which one population may undergo
enhanced metabolic activity while the other undergoes decreased
proliferation, the use of the two assays together may provide a better
understanding of the system.
The significance of this metabolic activation to inhibition of T
cells described in the main body of this study is unclear, although it
may be related to apoptosis. The induction of apoptosis, the apoptotic
process itself, and elimination of apoptotic cells by phagocytes can all
involve the generation of reactive oxygen intermediates (Buttke and
Sandstrom, 1994; Bandres et al., 1993). The production of ROI is
linked to several mitochondrial dehydrogenases, and phagocytic cells
are known for their ability to produce these reactive species during a
process called "metabolic burst" (Langermans et al., 1994). However,
the fact that this metabolic activity is not detectable until the second
day, and is maximal on the third day (Figure 9), is in contrast to the
significant apoptosis seen by 24 hours. Phagocytosis and degradation
of the apoptotic T cells by monocytes may be increased in the 2-3 day
time period, but metabolic activation is also seen in adherent
monocytes treated with Q5/13 alone, in which the activated monocytes
do not form giant cells and do not appear to have phagocytosed. It is
possible however, that the signal produced by class II molecule ligation
is by itself a signal for upregulation of ROI in anticipation of active
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phagocytosis. In support of this, others have found that freshly
isolated, non-activated macrophages do not phagocytose apoptotic T
cells, but are quite efficient at doing so after activation (Charles Surh,
La Jolla Allergy and Immunology Institute, La Jolla, Ca., personal
communication). Physiologically, high avidity recognition of Ag-MHC,
indicating either autoreactivity or recent phagocytosis of large amounts
of an immunogen, may prime monocytes for enhanced phagocytic and
bactericidal activity.
Part of the difficulty in interpreting this finding is the lack of
specificity in the MTT assay. While this assay is described as
measuring "mitochondrial" succinate dehydrogenase activity (Rai-elBalhaa et al., 1985), numerous other dehydrogenases have been shown
to reduce tetrazolium reagents to formazan products. Specifically, the
MTT and other tetrazolium salt assays have been used to measure
lactate dehydrogenase, succinate dehydrogenase, glucose-6-phosphate
dehydrogenase, isocitrate dehydrogenase, glutamate dehydrogenase,
and glycerol-3-phosphate dehydrogenase activity (Yomo et al., 1992;
Huang et al., 1994). Further biochemical characterization of the
enzymes that are upregulated following class II molecule ligation would
be helpful in understanding the role of metabolic activation in this
system.
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4.2

Patterns of Inhibition by Anti-MHC Class II mAb Reveal

Differences in Mitogenic Activation Between Concanavalin A
and OKT3.
Numerous anti-MHC class II antibodies have been evaluated for
their ability to block mitogenic activation of PBMC, in both previous
work by others (Akiyama et ah, 1985, Manzo et ah, 1990, Ruggierro et
ah, 1991) and in the preliminary experiments that led to the work
described in this manuscript. In the preliminary work in this
laboratory, however, one mAb, 417, was discovered to inhibit most
T cell activators, but did not inhibit OKT3. In combination with other
mAb, particularly Q5/13 (which is one of the best inhibitors), it was
possible to describe two independent but related experimental systems
which could be used to better understand mitogenic activation and
inhibition. In one case, one mAb (417) is paired with two activators
(OKT3 and ConA) to probe for differences between these activators. In
the other, two mAb (Q5/13 and 417) are paired with one activator
(OKT3) to probe for differences in the inhibition process. These two
systems can then be recombined to develop a comprehensive model of
activation and inhibition.
A striking difference was noted between the inhibition kinetics of
ConA and OKT3 by Q5/13. In experiments in which Q5 /13 was added
to PBMC cultures either before or after the addition of mitogen,
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inhibition of OKT3 mitogenesis is fairly consistent whether Q5/13 is
added hours before or hours after OKT3. In these experiments, a
gradual loss of inhibition is seen when Q5/13 is added more than two
hours after OKT3. For inhibition of ConA-mediated activation
however, there is a short period of time in which ConA-treated cells are
completely resistant to the inhibitory effects of Q5/13. This refractory
period of approximately one hour begins when ConA is added only a few
minutes before the anti-class II mAb. If Q5/13 is added 15-30 minutes
after ConA, no inhibition is seen at all. The inhibitory effect of anti
class II mAb returns to normal after 60-90 minutes, and then gradually
lessens as it does for inhibition of OKT3.
Despite the fact that OKT3 induces proliferation in both CD4
and CD8+ T cell subsets, and only CD4+ T cells show restriction for
MHC class II molecules (occasionally rare CD8+ T cells will show class
II molecule restriction), anti-class II mAb can completely inhibit (>95%)
the mitogenesis induced by OKT3 (Figure 6, Ruggiero et al., 1987).
T cell stimulation induced by antigen, mixed lymphocyte culture,
and superantigen is dependent on crosslinking of TCR to MHC.
Superantigen differs from the other MHC-dependent mitogens in being
neither peptide specific nor MHC restricted. sAg crosslinks TCR and
MHC by binding to a monomorphic epitope of class II molecules
outside the groove (Dellabona et al., 1990). The mechanism for ConA
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activation, however, is not well characterized, although it is mediated
by binding to a-D-mannose or a-D-glucose residues of cell surface
glycoproteins (Powell and Leon, (1970). In contrast, OKT3 activation is
mediated by direct crosslinking of TCR-CD3 on T lymphocytes and is
dependent on FcRI expression on APC for full activation (Ceuppens et
al., 1988; Ceuppens and Van-Vaeck, 1989).
I propose here that the tetravalent ConA acts by binding to
mannose residues on MHC and the TCR-CD3 complex, effectively
crosslinking TCR for T cell activation (Figure 29). High-mannose type
carbohydrate side chains have been identified on both the a and
(3 chains of MHC class II molecules in the linker region between the
al and a2 or (31 and (32 domains, respectively (Charron and McDevitt,
1980). This model for the mechanism of ConA can explain the
refractory period in which ConA-activated cells are resistant to anti
class II mAb inhibition. Pre-incubation with ConA results in binding of
ConA to class II molecules, which then blocks the binding of anti-class
II mAb. After 60-90 minutes, patching, capping, and endocytosis of the
crosslinked class II molecules is accompanied by de novo expression of
class II molecules. These newly expressed class II molecules are now
available for binding by anti-class II mAb, and inhibition returns.
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Figure 29. Proposed model for MHC-dependent concanavalin-A
activation of T lymphocytes.
The data presented here regarding mAh
417 indicate that inhibition of ConA-mediated T cell activation is
passive. The time-course of inhibition shown in Figure 10 also
indicates that this inhibition is mediated by inhibition of ConA binding,
not TCR-MHC interaction. This is most easily explained with a model
of ConA activation which parallels that of superantigen. That is, ConA
directly cross-links TCR and MHC through binding of high mannose
residues which exist in the inter-domain regions of both the alpha and
beta chains of class II molecules. Binding of mAb to class II molecules
in such a polymorphic region would inhibit binding of ConA and
subsequent crosslinking. This is shown in contrast to OKT3, which
crosslinks TCR independent of class II molecules. This model also
accounts for the relative specificity of ConA for CD4+ T cell activation,
since MHC class I molecules have much lower levels of high-mannose
type glycosylation.
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I also propose that the major difference between OKT3 and the
other mitogens is in the requirement for direct involvement of class II
molecules. OKT3 bypasses this requirement by crosslinking TCR and
CD3 directly, and can therefore be said to act in an MHC-independent
manner. Since there is no competition between the binding of anti
class II mAb and OKT3, inhibition must be mediated by an active
mechanism, as described in the following sections, and therefore can
inhibit CD4+ or CD8+ T cells, and can do so regardless of whether the
mAb are added before or after OKT3.
The dichotomy between inhibition of class II molecule-dependent
and -independent activators may not be absolute. Preincubation of
PBMC with anti-class II mAb may block MHC-dependent activation
(lectin or superantigen) in a passive manner by blocking these agents
from binding to MHC, while inhibition of MHC-dependent activation
after the refractory period may be an active mechanism involving APC
activation by class II molecule ligation similar to the inhibition of
OKT3 activation.
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4.3

Steric Inhibition and Low Affinity Binding as a Model for

the Inhibition of ConA and Enhancement of OKT3
Activations, Respectively, by mAb 417.
The activity of anti-CD3 mAb has been shown to be mediated by
effective aggregation of the TCR-CD3 complex. This is accomplished
with soluble anti-CD3 by Fc receptor binding on adjacent antigen
presenting cells (Ratcliffe et al., 1992). The effectiveness of these
antibodies is sensitive to class, with IgG2a and 2b having the greatest
affinity for FcRI, the predominant Fc receptor.
The inhibitory ability of anti-class II mAb appears to be
independent of antibody class or Fc-receptor binding (Ruggiero et al.,
1991) since antibody class did not correlate with inhibitory ability, and
Fab fragments of inhibitory anti-class II mAb were still able to partially
inhibit OKT3-mediated T cell proliferation. Similarly, the inability of
mAb 417 to inhibit OKT3-mediated mitogenesis, despite it’s reactivity
with the same molecular species as Q5/13, appears unrelated to it's
IgM class, since other IgM anti-class II mAb are able to inhibit OKT3.
This leaves the possibility that affinity or fine epitopic specificity
determines the ability of anti-class II mAb to inhibit MHC-independent
activation.
417, however, does not simply fail to inhibit OKT3-induced
mitogenesis. In optimal doses comparable to those in which 417
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inhibits ConA or SEA mitogenesis, 417 enhances the thymidine
incorporation of OKT3 mitogenesis.
MAh 417 appears to inhibit MHC-dependent mitogenesis by
passively blocking the binding of these mitogens to MHC class II
molecules. I propose that 417 cannot inhibit class II moleculeindependent T cell activation because of its failure to activate APC, and
the failure of 417 to activate APC is a function of it’s low affinity.

4.4

Evidence for an Active Mechanism in the Inhibition of

OKT3 Mitogenesis by Q5/13: Metabolic Activation, Inhibitory
Cytokine Release, and T Cell Apoptosis
The activation signals induced in the T cell by the interaction of
the TCR with Ag-MHC are well-established (Weiss, 1993). Much less is
known, however, of the activation signals in APC, and few models have
appreciated that the signal provided by TCR-Ag-MHC interaction is bi
directional. This is understandable, considering that activation is
typically measured within the T cell population, i.e. effector function
(cytolysis or cytokine release) or proliferation. Since antigen,
superantigen, and lectins all may rely on direct interaction of TCR and
MHC, the research described in this manuscript has focused primarily
on the mAb Q5/13 and OKT3 in an attempt to dissect the independent
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roles that TCR and MHC, and thus the T cell and APC, might play in
high avidity TCR-MHC interactions.
To rule out the possibility that anti-class II mAb may have a
direct effect on T cells, T cell expression of class II molecules was
followed by flow cytometry after stimulation with OKT3. Consistent
with previous reports by others (Ko et al., 1979), class II molecule
expression on T cells was not upregulated until 4-6 days after
stimulation. Even at day 6, the level of expression was 15-fold less
than that of resting B cells. Also, anti-class II mAb have been shown
to inhibit T cell activation in mouse models, despite the fact that class
II molecules have not been shown to be expressed in detectable
amounts on murine T cells even following stimulation (Lorber et al.,
1982). Finally, class II molecule ligation enhances, rather than
inhibits, proliferation of T cell clones (Spertini et al., 1992).
Class II MHC has been assumed to regulate APC secretion of
positive regulatory cytokines. However, previously published work
indicates very different responses of B cells and APC's to class II
molecule ligation. Class II molecule ligation of B cells is costimulatory
for proliferation, antibody production, and upregulation of cell adhesion
molecules and costimulatory ligands such as B7 (Nabavi et al., 1992).
In contrast, class II molecule ligation of monocytes leads to decreased
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expression of cytokines such as IL-lp and IL-6 (Racioppi et al., 1990)
and formation of multinucleated giant cells (MGC) by fusion (Orentas
et al., 1992). The data described here also suggests that monocytes,
not B cells, are responsible for the downregulation of T cell
proliferation.
OKT3 has been shown to induce aggregation of PBMC (Wagner et
al., 1993), and anti-class II mAb can induce homotypic aggregation of
B cells (Ramirez et al., 1992). Both of these findings have been shown
to be mediated by de novo expression of cell adhesion molecules
(Brick-Ghannam, 1991). Data presented on this manuscript shows
that mAb Q5/13 is also able to induce aggregation of PBMC. However,
in contrast to the antagonism of OKT3 mitogenesis, Q5/13 and OKT3
are agonistic in the induction of PBMC aggregation. The aggregation
induced in all three cases was inhibited by the cytoskeletal inhibitor
Cytochalasin D. These findings are interpreted here as evidence that
the primary activation signal induced in T cells by OKT3 is not blocked
by Q5/ 13. Rather, the combined stimulation of T cells and APC, and
upregulation of cell adhesion molecules on both cell subsets, leads to
enhanced aggregation. This aggregation can be blocked by interfering
with the transport of these cell adhesion molecules to the cell surface
by treatment with Cytochalasin D. This indicates that Q5/13
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inhibition of T cell mitogenesis occurs downstream of the primary T cell
activation signal.
The metabolic activation induced by Q5/13 alone follows a dosedependent curve with similar shape and concentration range as the
inhibition of OKT3 mitogenesis by Q5/13. This finding indicates that
class II molecule-mediated metabolic activation and mitogenic
inhibition may be causally associated. To reinforce this association
further, all of the anti-class II mAb that block OKT3 mitogenesis were
found to induce metabolic activation, and the mAb that did not block
OKT3 mitogenesis (417) did not induce metabolic activation.
mAb Q5/13 was also found to induce tyrosine phosphoiylation
(Figure 11) in the Raji cell line, a B cell line derived from a Burkitt's
lymphoma that, unlike other B cell lines, does not increase tyrosine
phosphorylation in response to IgM crosslinking (Law et al., 1992).
This indicates that MHC class II molecules have, or are physically
associated with, tyrosine kinase activity, and that tyrosine
phosphorylation is at least one mechanism for its signal transduction.
It also indicates that the tyrosine kinase(s) involved in IgM signal
transduction in B cells are distinct from the tyrosine kinase(s) of MHC
class II molecule signal transduction, since the Raji cell is deficient in
it’s response to the former but not the latter. Thus, activation of B
cells through class II molecules may be physiologically distinct from
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activation through IgM, and the Raji cell line may provide a model for
discriminating between these two pathways of B cell activation.
The finding that 417 does not induce tyrosine phosphorylation,
together with the previous finding that it also does not activate PBMC
metabolically nor does it block OKT3 mitogenesis, further reinforces
the concept that tyrosine phosphorylation may be the pathway between
class II molecule ligation and metabolic activation in APC, and that
this activation is causally related to OKT3 inhibition.
Adherent cells pretreated with Q5 /13 were able to inhibit OKT3
mitogenesis of freshly added T cells in a dose-dependent manner by
more than 50%, even though fresh untreated accessory cells were also
present. PBMC cultured with insoluble Q5/13 on one side of a 0.2 mm
membrane were shown to inhibit OKT3 activation of PBMC on the other
side of the membrane. Although antibody transfer from the adherent
cells to the fresh APC was not ruled out in the pretreatment
experiment, "leakage" of the antibody from the sepharose beads in the
insert experiment seems to have been ruled out, since no increase in
metabolic activation was seen in the wells. This indicates that an
inhibitory factor released by Q5/13-treated APC can override the
normal accessory signals released provided by fresh untreated APC.
The reduced level of inhibition seen in both of these experiments
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(50-60% versus 95% in direct inhibition experiments) indicates that
although the mediator of inhibition may be released as a soluble factor,
there may be a surface bound form that is more effective.
Anti-class II mAb have been shown to cause apoptosis in a small
percentage of resting, but not activated, splenic murine B cells. In this
manuscript it is shown that anti-class II mAb causes apoptosis of
PBMC as assayed by gel electrophoresis of fragmented DNA. This
apoptosis is dose dependent and is greatly enhanced in the presence of
costimulation of T cells. Although there is also an increase in
apoptosis of T cells purified from these cultures by anti-CD2/CD3
magnetic separation, this apoptosis is minimal compared to the
apoptosis of the PBMC culture as a whole. This finding seems to
support the hypothesis that mononuclear giant cells are phagocytosing
the apoptotic T cells, making them unavailable for affinity purification.
Numerous flow cytometry experiments using ethidium bromide
staining as a marker of apoptosis failed to identify an increase in
apoptotic cells in either the CD2+ or CD2 lymphocyte subsets. In
these experiments, it was also noted that monocytes failed to appear
in their normal forward scatter vs. side scatter position when PBMC
were treated with both OKT3 and Q5/13. Further analysis of these
cultures after treatment with EDTA/trypsin to ensure recovery of
adherent cells confirmed the disappearance of normal monocytes from
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these cultures. Fluorescent microscopy of these cultures with DNA
binding fluorochromes identified massively multinucleated giant cells
within 24 hours of culture with OKT3 and Q5/13. The formation of
MGC from monocytes by class II molecule ligation has been described
(Orentas et al., 1992), and has been shown to be dependent of the
presence of a macrophage fusion factor that has not been identified,
but is known to be released from activated T cells. This provides
further evidence that anti-class II mAb do not block the activation of
T cells by OKT3, since some level of T cell activation is required for
MGC formation (Q5/13 alone does not induce MGC formation in
PBMC). Notably, the induction of MGC in purified monocytes by anti
class II mAb showed MGC containing as many as 25 nuclei each at
48 hours (Orentas et al., 1992), while the MGC described in this
manuscript show as many as 50-250 nuclei each at 24 hours. This
high number of nuclei at such an early time is suggestive of a process
other than monocyte fusion, perhaps fusion combined with
phagocytosis of apoptotic T cells.
In support of this, the pathologic conditions in which
mononuclear giant cells are known to occur are characterized by
conditions that require phagocytosis of large amounts of antigens that
are difficult to digest. If class II molecule ligation provides the signal
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for enhanced phagocytosis, this can explain both the formation of MGC
and the upregulation of metabolic enzymes.
In contrast to the majority of the flow cytometry experiments,
two flow cytometry experiments identified high levels (80-95%) of
apoptosis in CD2+ lymphocytes. In these experiments, apoptosis was
dose dependent for both Q5/13 and OKT3, implying activation
dependent apoptosis of T cells in response to class II molecule ligation
of APC. These same experiments showed no loss of the normal
monocyte population, further supporting the contention that giant cells
in the previous experiments were responsible for removal of apoptotic
T cells.
Many attempts were made to identify the cause of the mutually
exclusive appearance of either multinucleated giant cells or apoptotic
T cells staining with ethidium bromide. In all of the following
experimental variables, PBMC were tested for apoptosis by ethidium
bromide flow cytometry method at 24 hours after stimulation with
optimal doses of OKT3 and Q5/13 unless otherwise indicated:
1) To evaluate whether the induction of apoptosis may take
longer than 24h, cell cultures were analyzed at 24, 48, and 72 hours.
2) To evaluate whether a disease state may correlate with the
presence or absence of apoptosis (the primary donor experienced cold
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symptoms during some of these experiments), PBMC from two other
healthy donors were tested.
3) Inhibition of oxidative burst by the Goode’s buffer HEPES has
been previously shown (Ginsburg et al., 1993), and oxygen radicals
produced by oxidative burst have been shown to play several roles in
apoptosis (Buttke and Sandstrom, 1994; Bandres et al., 1993). Since
this buffer is commonly used in cell culture media in our laboratory, I
tested for apoptosis in media containing Na-bicarbonate buffer alone or
with various concentrations of HEPES.
4) To test whether the induction of T cell apoptosis may be
sensitive to media freshness or to normal variations of factors present
in fetal bovine sera, complete RPMI media was prepared from
hybridoma-grade fetal bovine serum obtained from several different lots
or suppliers, including the specific lot and supplier used in the
previous two experiments that showed apoptosis.
5) Heparin has been shown to inhibit the DNA fragmentation of
apoptosis (Maeda et al., 1993). To see if PBMC sensitivity to apoptosis
is affected by prolonged standing in the heparin used when drawing
peripheral blood, PBMC were purified immediately or after 30 min
incubation from blood samples were drawn in heparin or EDTA and
tested for apoptosis.
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6) To rule out any gross errors in dilution of reagents in those
experiments that showed apoptosis, reagents were titrated over a
three-log range, both above and below optimal concentrations, in
parallel with a thymidine incorporation experiment using the same
cells and reagent concentrations as a positive control for activation and
inhibition.
7) To rule out variations in different samples of Q5/13, multiple
sources of Q5/13 (protein-A purified, supernatant from spent cultures
grown in complete RPMI, supernatant from spent cultures grown in
serum-free media, or ascites) were titrated and tested for apoptosis.
8) Since the ethidium bromide flow cytometry method for
apoptosis specifically identifies apoptotic cells that have lost
membrane integrity, and since several reports have described delayed
loss of membrane integrity in certain systems, PBMC were assayed for
apoptosis by looking for a sub-GO/G1 peak in propidium iodide flow
cytometry cell cycle analysis.
9) A role for free iron has been demonstrated in the induction of
some types of apoptosis. Since one of the early batches of purified
Q5/13 was purified in a way in which citrate buffer may have been
present, and red cells are present in significant numbers in FicollHypaque-purified PBMC, the affect of ferrous citrate on induction of
apoptosis was tested by including citrate buffer in the culture media.
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10) Although 3H-thymidine experiments had not shown any
kinetic variation with respect to addition of Q5/13 and OKT3 at
different times, I tested the possibility that it played a role in whether
T cells were induced to undergo apoptosis or anergy by testing for
apoptosis in cultures that had the two reagents added simultaneously
or separated by 30-60 minutes.
None of the above experiments were successful in reducing the
loss of normal monocytes as identified by light scatter characteristics
nor in increasing the number of apparent apoptotic T lymphocytes
identifiable by ethidium bromide fluorescence.
In contrast, induction of apoptosis by Q5/13 as measured by
DNA fragmentation is very reproducible. To account for these apparent
conflicts, I propose that the combined treatment of OKT3 and Q5/13
leads to T cell apoptosis and formation of highly phagocytic MGC.
These MGC rapidly phagocytose the apoptotic T cells, making the
T cells inaccessible for analysis by flow cytometry or purification by
immunomagnetic separation. The MGC are created by fusion of
activated monocytes in the presence of a T cell factor so they no longer
appear in the typical scatter position when analyzed by flow cytometry.
However, purification of fragmented DNA from these cultures includes
the DNA from the phagocytosed T cells, and thus shows significant
levels of apoptosis.
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4.5

Preliminary Evidence for the Role of Anti-Class II

Autoantibodies in AIDS Pathogenesis.
gp41 of HIV has been shown to have regions of sequence
homology with class II molecules, and antibodies purified from HIV+
individuals show crossreactivity to class II molecules (Golding et al.,
1988). Protein A purified antibodies from HIV were tested to see if
these antibodies show characteristics similar to anti-class II mAb.
PBMC cultured with Protein A-purified IgG from HIV-positive, but not
HIV-negative, patient serum shows inhibition of OKT3 activation
similar to Q5/13. In addition, this inhibition of OKT3 mitogenesis is
paralleled by an increase in MTT cleavage. Finally, HIV-Ab were able to
induce PBMC aggregation. Thus, protein A-purified IgG from HIV+
patient serum, in physiologic concentrations, has an effect on fresh,
HIV-negative PBMC that parallels that of mAb Q5/13.
Alternatively, this finding may be explained by the possibility of
contaminating virus in the purified HIV-Ab leading to in vitro infection.
HIV infected cells have been shown to induce syncitia in vitro, and are
resistant to T cell mitogens, and one may propose that the infection or
the syncitia formation may be responsible for upregulation of
mitochondrial enzymes. However, the Ab preparation used in these
experiments was treated at 65 °C for 1 hour to heat-inactivate any
contaminating virus. In addition, the amount of contaminating virus is
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likely to be small, much less than that found in serum, which is
already minimal. Finally, since fresh uninfected cells are used in this
experiment, the contaminating virus would have to rapidly infect a
majority of the cells in order to exert an effect comparable to Q5/13.

4.6

Model and Significance
The avidity model of T cell development can be applied

physiologically to thymic selection, peripheral tolerance, and regulation
of the immune response. In each situation, high avidity TCR-Ag-MHC
ligation induces cell death, while low avidity ligation leads to T cell
activation. The paradox of this model lies in the fact that the same
receptor, TCR, is postulated as being able to provide two different, and
opposite, signals when binding to the same ligand at different affinity
or concentration. Here, I show preliminary evidence for an avidity
model of T cell development in which the regulation of T cell activation
is controlled by the relative avidity thresholds for signal transduction
by the TCR and the MHC (Figure 30). In this model, the low avidity
signal is provided through the TCR and the high avidity signal is
provided through the MHC. To accomplish this, the avidity threshold
for signal transduction through MHC must be higher than the
threshold for signal transduction through the TCR.
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Thus, high affinity binding of mAh (Q5/13) to MHC class II
molecules on APC mimics high avidity TCR-Ag-MHC recognition, which
induces signal transduction through both the TCR and MHC. The MHC
signal leads to APC activation, via tyrosine phosphorylation, and
subsequent release of an inhibitory cytokine that delivers the negative
signal required to induce T cell apoptosis. Low affinity binding of mAb
(417), below the threshold required for class II molecule signal
transduction but still above the TCR threshold, does not provide a
direct signal through MHC class II molecules, but may enhance the
aggregation of costimulatory molecules on the APC to provide a positive
signal for release of proliferative cytokines that are necessary to
cooperate with the TCR signal for T cell activation. Both of these
conditions are then consistent with current models of activationinduced apoptosis and T cell activation in which two signals are
required, the primary signal being provided by OKT3, and the secondary
signal, which determines proliferation or apoptosis, being provided by
the APC.
The most attractive possibility in this model is that different APC
(dendritic cells, thymic epithelia, B cells, monocytes, etc.) may respond
differently to class II molecule ligation, eliminating the one-receptor,
two-signals dilemma of the current avidity model. In particular, this
model may apply to immune regulation with respect to the potential
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avidity of B cell-T cell interactions compared to "professional"
APC/T cell interactions. B cells have the greatest amount of MHC,
present only antigen-related peptides in their MHC, and function at
the peak of the immune response, after which downregulation of T cells
is reasonable.
This model in which class II molecule-positive cells play a role in
discrimination of avidity can provide new interpretations of current
literature in several models.
Superantigen is known to cause both proliferation and deletion of
peripheral mature T cells. The mechanism of superantigen has been
shown to involve direct crosslinking of MHC class II molecules and
TCR through interaction with monomorphic epitopes on MHC and
reaction with specific Vp regions of TCR (Dellabonna et al., 1990).
Since the optimal concentration of sAg is very low for T cell
proliferation of PBMC (10-50 pg/ml), the level of MHC crosslinking at
this concentration may not be enough to cause a signal through class
II molecules. At higher concentrations however, the threshold for
class II molecule signaling may be reached leading to apoptosis rather
than proliferation of the T cells.
This same model can similarly explain the relatively narrow range
of ConA concentrations that are mitogenic for T cells. At lower
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concentrations, the degree of TCR crosslinking is insufficient for T cell
activation, while at higher concentrations, the degree of class II
molecule crosslinking is sufficient to induce release of an apoptotic
signal.
Similarly, altered peptide ligands have recently been used as a
model for discriminating between non-selection, activation, and
deletion induced by peptides of slightly different affinity. These
studies have shown that in T cell lines specific for an immunogenic
peptide, a signal amino acid change in the presented peptide may
result in a peptide that still binds MHC, but may fail to stimulate or
may be antagonistic to native antigen stimulation of this T cell line.
The non-stimulatoiy peptides have been shown to result in insufficient
TCR-Ag-MHC avidity for TCR signaling, while the antagonistic peptides
result in high avidity TCR-Ag-MHC ligation. Similarly, at high
concentrations the immunogenic peptide itself may induce apoptosis
rather proliferation. These findings are consistent with the model of
regulation of T cell activation by a higher threshold of MHC-dependent
signaling that leads to apoptosis of otherwise-activated T cells.
Previous studies have shown that the affinity of TCR for immunogenic
peptides is extremely low, around lO 5 kd. This is consistent with the
very low concentration of OKT3 needed to elicit T cell activation
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(10 ng/ml) compared with the minimum amount of Q5/13 needed to
induce apoptosis (1 pg/ml).
Several comments concerning the role of affinity in T cell
responses can be made when T cell affinity is viewed teleologically.
Unlike the B cell, in which the receptor is also the mediator of any
effector functions, the TCR has no need for affinity maturation as the
B cell receptor does. Antibodies are dependent on having as high a
binding affinity as possible in order to be effective (and are considered
among the highest affinities of protein-protein interactions), while TCR
needs only to have enough affinity to result in signal transduction.
TCR with increased affinity represent a potential hazard with regard to
autoimmunity, since a T cell with very high affinity for Ag-MHC can
mediate full effector functions given sufficient low affinity interaction
with MHC and a self peptide. Thus, only T cells with moderate-low
affinity are selected. The role of the ARC in regulating this affinity
might be supposed based on findings that any MHC-bearing cell (even
transfected fibroblasts) can induce positive selection, but negative
selection seems to be restricted to thymic stromal cells, bone marrowderived professional ARC. This implies that positive selection is
passive with regard to the ARC, while negative selection is active, or
that overexpression of MHC (to achieve adequate avidity) is required to
induce negative selection using non-APC.
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The putative APC signal responsible for mediating this apoptosis
has not been identified in the work. However, the recently identified
FasL appears to be likely candidate. Fas is upregulated on activated
T cells within 4 hours of T cell stimulation (Seamus Martin, La Jolla
Allergy and Immunology Institute, La Jolla, Ca., personal
communication), and ligation of Fas with anti-Fas mAb leads to
apoptosis. Upregulation of Fas following OKT3 stimulation would
account for the activation dependence of apoptosis seen in the work
described in this manuscript. In addition, reports have shown both
that mature Fas- T cells are resistant to activation-induced apoptosis
(Bossu et al., 1993) and that Fas is required for activation-induced
apoptosis in T cells (Ju et al., 1995; Brunner et al., 1995). FasL has
been identified as a member of the tumor necrosis factor family, which
is known to include both soluble and surface-bound forms (Nagata et
al., 1994).
It has not been possible in this study to rule out the possibility
that class II molecule ligation mediates both apoptosis and anergy in
activated peripheral T cells. T cells found in peripheral blood are
approximately 50% memory cells and 50% naive cells, with very few
activated cells, and these are further divided in CD4+ and CD8+
subsets. It is possible that subsets of peripheral T cells are inhibited
differently by complementary mechanisms in this system.
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The concept that high affinity mAh binding to MHC class II
molecules may lead to T cell apoptosis can also be applied to AIDS
pathogenesis. The gp41/120 could initiate a humoral autoimmune
state by inducing antibodies that cross-react with MHC class II
molecules that are initially of low affinity. Through minor mutations
and affinity maturation occurring over time, these antibodies
eventually develop an increased affinity for MHC class II molecules
until they mimic the effect of high avidity MHC ligation. Others have
already described an HLA-linkage with respect to the length of time
between HIV infection and development of AIDS, which may represent
haplotypes that show stronger crossreactivity to HIV-Ab.
One mechanism of HIV immunosuppression can be explained on
the basis of a factor, generated by APC in response to cross-reactive
anti-class II antibodies, which primes T cells for activation-induced
apoptosis. This elimination of activated T cells would explain a
number of laboratory findings and hallmark symptoms of AIDS- decline
in T cell counts in the presence of normal numbers of APC (reflected as
a both a lack of expansion in peripheral memory cells and increased
apoptosis of developing T cells), decreased T cell response to
phytohemagglutinin, the advent of opportunistic infections, enhanced
apoptosis following OKT3-stimulation, and even immunodeficiency
itself. This model may also help to explain several of the paradoxical
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findings in AIDS. For instance, despite a lack of CD4+ helper T cells in
AIDS, many patients show lymphadenopathy and hypergamma
globulinemia, signs of B cell activation. Previous studies have already
shown that class II molecule ligation is a costimulus for B cell
activation. In addition, the formation of giant cells by monocytederived astrocytes in the brain (which may play a role in AIDS
dementia) may be explained on the basis of class II molecule ligation
by cross-reactive antibodies. It has been suggested that humoral
immunity to HIV may complicate the disease through other
mechanisms (such as in antibody-dependent endocytosis of virus
particles), and Abbott Laboratories recently delayed trials of HIV-Ig
therapy for prevention of neonatal transmission of HIV because of
concerns that it could actually enhance HIV infection.

4.7

Conclusion
The findings described in this manuscript argue against the most

current model of anti-class II mAh mediated inhibition of T cell
mitogenesis as a simple phenomenon of steric inhibition, but suggests
that this model does apply to class II molecule-dependent mitogens.
The mechanism for inhibition of OKT3 appears to be an active one
involving tyrosine phosphorylation, metabolic activation, and release of
an inhibitory cytokine.
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The above findings also argue against the use of anti-class II
mAb in investigating the potential role of MHC class II molecule signal
transduction in the release of positive cytokines for T cell proliferation
such as IL-1. While there appears to be a dichotomy between the role
of class II molecule signal transduction in B cells versus professional
APC, most anti-class II mAb, 417 excepted, may be of sufficiently high
affinity that they result in a negative signal through class II molecules.
The use of anti-class II mAb to show inhibition of T cell
activation has become a common method for showing class II molecule
dependence of superantigens. The above findings argue against the
interpretation of anti-class II mAb inhibition as an indication of direct
binding to class II molecules by mitogens. Instead, it is possible that
high affinity anti-class II mAb used in studies of superantigen binding
did not block binding, but rather caused APC activation leading to T cell
apoptosis. In this regard, mAb such as 417, which are identified as
non-stimulatory for class II molecules, may be better suited for
showing direct inhibition of binding.
At its extreme, this knowledge may impact the fields of
autoimmune disease and transplantation. If it is true that MHCdependent stimulation of accessory cells prime T cells for activationinduced apoptosis, then this may provide a novel mechanism for
therapeutic elimination of selfreactive clones.
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In summary, this study may help us to better understand the
physiology of T cell activation and inhibition by anti-class II antibodies.
The literature regarding novel pathologies of T cell activation is
growing, exemplified by HIV immunosuppression and the
immunodeficiencies resulting from defective signal transduction
(Chatila et al., 1989) or missing cell adhesion molecules (Gregory et al.,
1988). I hope that the findings of this study will help us to more
readily address the pathologic mechanisms associated with diseases of
T cell non-responsiveness, and enable us to apply these mechanisms
to diseases of inappropriate T cell activation.
At the very minimum, the findings described in this manuscript
may lay the foundation for an in vitro model of peripheral tolerance
induction, in which the relative roles of affinity, avidity, TCR and MHC
signal transduction, and their respective thresholds may be evaluated.

CHAPTER 5

A FASTER, CLEANER, AND SIMPLER METHOD FOR THE
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MOLECULAR WEIGHT APOPTOTIC DNA.
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5.1

Abstract
DNA cleavage into oligonucleosomes is a hallmark of eukaryotic

cells that die by apoptosis. Electrophoregrams of these fragments can
be divided into three regions- light nucleosomal multiples forming
discreet bands, heavier multiples forming a broad smear, and the
heaviest fragments of 50 and 300 kb produced during early stages of
apoptosis. The heaviest band is also seen in actively growing cultures
presumed to be non-apoptotic, and has been reported as evidence of a
low level of apoptosis within cell cultures. Here I have modified and
validated an affinity chromatography method for purifying DNA from
apoptotic cells. The DNA was protein free, RNA free, and ready for
electrophoresis in 15 min. Agarose gel electrophoresis of apoptotic or
non-apoptotic DNA purified by affinity chromatography were analogous
to those of alcohol-precipitated DNA. The band obtained from nonapoptotic cells was shown by restriction enzyme analysis to contain
mitochondrial DNA. Thus, mitochondrial DNA may often be copurified
with apoptotic DNA, and a high molecular weight band of DNA isolated
from cultured cells may represent mitochondrial DNA (mtDNA) rather
than low levels of apoptosis. Finally, this method is a rapid alternative
to current methods of purifying apoptotic and mitochondrial DNA, and
restriction enzyme analysis of mtDNA purified by this method may be a
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simple and rapid method for typing and monitoring the purity of cell
lines.

5.2

Introduction
Under physiologic conditions, cell death occurs by a gene-directed

(Sellins and Cohen, 1987; Shi et al., 1992), metabolically active
mechanism (Williams, 1991). This phenomenon is referred to
eschatalogically as programmed cell death, and morphologically as
apoptosis (Cohen, 1993). Programmed cell death is particularly
significant in processes that involve tissue remodeling (embryogenesis)
(Hinchliffe and Thorogood, 1974) or high cell turnover rates (T cell
development) (Smith et al., 1989). This death may also take place in
pathologic processes provided that cells have enough time to
implement this process (Payne et al., 1992).
Cytotoxic T cells (Duvall and Wyllie, 1986), y-irradiation (Skalka
et al., 1976), or glucocorticoids (Cohen and Duke, 1984) may trigger
apoptosis. Apoptosis is characterized morphologically by chromatin
condensation followed by disruption of the cell into membrane-bound
fragments. At the molecular level it is characterized by proteolysis and
cleavage of the genomic DNA between nucleosomes by a specific Ca + +
dependent endonuclease (Compton, 1991). When electrophoresed,
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these mono- and oligonucleosome fragments form a distinctive pattern
of bands in multiples of 180 bp ("ladder").
The standard methods for purifying apoptotic DNA prior to
electrophoresis are based on alcohol precipitation and
phenohchloroform extraction (Table I), and therefore are time
consuming. Although deproteination steps are skipped in some cases,
as many as five phenohchloroform extractions and alcohol
precipitations have been reported in purifying apoptotic DNA (Kaeck et
ah, 1993). These manipulations increase the DNA preparation time
especially when performed overnight. Also, when processing few cells
or cells with low apoptotic index, the apoptotic DNA may be too little to
form a visible precipitate, and therefore may be only partially recovered.
A better method for quantitative and qualitative purification
of apoptotic DNA would be welcome.
Standard methods for purifying mtDNA are similar, although they
usually require the additional step of making a crude mitochondrial
preparation first, in order to reduce contamination of the mtDNA with
genomic DNA. Restriction fragment length polymorphism (RFLP)
analysis of mtDNA has recently proved useful in constructing
anthropologic maps of population inheritance and migration.
Affinity chromatography methods for DNA purification have
recently been marketed as micro-method kits for the rapid isolation of
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plasmids from bacterial cultures [PlasmidQuik (Stratagene, La Jolla
Ca), Circleprep (Bio 101, La Jolla, Ca), Magic Minipreps (Promega
Corporation, Madison, WI), and others]. These commercial kits
combine alkaline cell lysis (Sambrook et al., 1989) with affinity
chromatography on proprietary DNA-binding resins, typically of
modified glass/silica. By using a neutral lysis solution with one of
these kits, I show that affinity chromatography can be applied to
purification of apoptotic DNA and outperforms the current precipitation
methods.

5.3

Materials and Methods

5.3.1 Cell culture
Peripheral blood mononuclear cells (PBMC) were isolated by
centrifuging 10 ml freshly drawn heparinized blood over 5 ml
Histopaque 1077 (Sigma Chemical Co., St. Louis, MO) for 30 min at
200 x g. The buffy coat was collected and washed twice in RPMI 1640
(Mediatech, Inc., Herndon, VA). Raji cells (American Type Culture
Collection, Rockville, MD) or PBMC were cultured in 25 cm2 tissue
culture flasks and placed in a humidified incubator containing 5% CO2
at 37 °C. The cultures were grown in complete RPMI medium [RPMI1640, suplemented with 10% fetal bovine serum (HyClone Laboratories,
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Inc., Logan, Utah), 2 mM L-glutamine, 50 mg/ml gentamicin, and
10 mM HEPES].
Raji cells (2xl05 cells/ml) were also cultured with 0.1 mCi/ml
3H-thymidine for 72 hr. Cells were then y-irradiated (2750 rads) to
induce apoptosis and recultured for 24 hr. PBMC were irradiated with
150, 300, or 600 rads and cultured for 24 hr.

5.3.2 Preparation of apoptotic DNA by affinity chromatography.
The Magic Minipreps DNA Purification System (Promega
Corporation, Madison, WI) was used according to the product insert,
except that a modified lysis solution (1% SDS) was substituted for the
Lysis Solution (1% SDS, 2 M NaOH) of the kit. Briefly, cells were
washed two times in cold PBS (1.9 mM NaPLPO^ 8.1 mM Na2HP04,
0.15 M NaCl, pH 7.3), pelleted, and resuspended in 200 pi of the
Resuspension Solution [50 mM Tris, pH 7.5, 10 mM EDTA, 100 pg/ml
ribonuclease (RNase) A]. Cells were then lysed by mild vortexing with
200 pi of the modified lysis solution. Protein and SDS were
precipitated by the addition of 200 pi of the Neutralization Solution
(2.55 M potassium-acetate). This precipitate and the unfragmented
DNA were pelleted by centrifugation for 10 min at 10,000 x g. The
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supernatant was transferred to a microcentrifuge tube, gently mixed
with 1 ml DNA Purification Resin, and transferred to a 3 ml syringe
attached to a Minicolumn. The slurry was slowly pushed through the
attached column, washed with 2 ml of Column Wash Solution (0.2 M
NaCl, 20 mM Tris, 5 mM EDTA, pH 7.5 in 50% ethanol), and spun diy
for 30 sec at 10,000 X g. Fragmented DNA was eluted in 25 pi of warm
(37 °C) Tris-acetate-EDTA buffer (TAE) (40 mM Tris-acetate, 2 mM
Na2EDTA, pH 8.5) by centrifugation for 30 sec at 10,000 x g into a
microcentrifuge tube.

5.3.3 Preparation of apoptotic DNA by isopropanol precipitation
The method of Duke and Cohen (Duke and Cohen, 1992), as
outlined in Current Protocols in Immunology, was used without
modification. Briefly, cells were washed two times in cold PBS,
pelleted, and lysed in 500 pi Triton-Tris-EDTA [0.2% Triton X-100 in TE
buffer (10 mM Tris-Cl, 1 mM Na2EDTA, pH 7.6)]. Unfragmented DNA
was pelleted by centrifugation for 10 min at 10,000 x g. The
supernatant was transferred to a clean microcentrifuge tube and
vortexed first with 0.1 ml ice-cold 5 M NaCl and then with 0.7 ml icecold isopropanol. Fragmented DNA was precipitated by overnight
incubation at -20 °C. Precipitated DNA was pelleted by centrifugation
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for 10 min at 10,000 x gand washed with 1 ml ice-cold 70% ethanol.
The wash was removed by blotting and the DNA was dried under
vacuum. The DNA was then redissolved overnight in 25 (il loading
buffer (25% glycerol, 100 mM Na2EDTA) at 37 °C. Some samples were
redissolved in a loading buffer containing 250 pg/ml RNase A.

5.3.4 RFLP analysis
Multiple samples of DNA were purified by affinity chromatography
using alkaline lysis from 2xl06 non-apoptotic Raji cells. The DNA was
eluted from the column in 20 |il sterile deionized water, and either
refrigerated at 4 °C or cut for 1 hr at 37 °C following the addition of 2 ^1
Hindi (10 U/(li1) enzyme and 2.5 pi concentrated enzyme buffer
(Promega Corporation, Madison, WI). Five microliters of loading buffer
were added to the the DNA to stop the digest, and DNA was
immediately loaded into the agarose gel.

5.3.5 Agarose gel electrophoresis
Redissolved DNA or eluted DNA were added to 5 pi of loading
buffer and loaded into wells of 1.2% (mtDNA RFLP) or 2.0% (apoptotic
DNA) agarose gels [3 parts Low Melt Agarose to 1 part DNA-Grade High

151
Melt Agarose (Fisher Scientific, Fair Lawn, NJ) in TAE buffer, 0.5 mg/ml
ethidium bromide]. The gels were electrophoresed at 5 V/cm for 2 hr in
TAE buffer with 0.5 mg/ml ethidium bromide. EcoRI/HinDIII digested
lambda-phage DNA (0.75 ^ig) was run as a molecular weight standard.
The gels were photographed under UV light using Polaroid 665 film.

5.3.6 B-Scintillation Counting
Twenty-five microliters of purified labeled DNA was vortexed with
5 ml scintillation fluid (Scintiverse E, Fisher Scientific, Pittsburgh, PA).
The DPM were calculated automatically during counting in a Beckman
LS-3801 scintillation counter. To calculate the apoptotic index, the
pelleted high molecular weight DNA was also recovered from the
centrifuge tube and counted similarly to the apoptotic DNA.

5.4

Results

5.4.1 Apoptotic DNA can be purified by affinity chromatography
PBMC were irradiated to initiate apoptosis and then cultured.
After 24 h, the cells were lysed with the Lysis Solution supplied with
the Magic Miniprep DNA Purification System or with a modified lysis
solution containing 1% SDS, without NaOH. After centrifugation, the
soluble DNA was adsorbed on the Purification Resin, transferred to the
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minicolumn, eluted, and electrophoresed. The DNA obtained from the
cells that were lysed by using the modified solution showed a typical
ladder of bands 180-bp apart (Figure 32, lane 8), while the DNA
obtained by using the commercial lysis solution formed a diffuse smear
(Figure 32, lane 7) often with a few faint bands only 75 bp apart
(Figure 33, lanes 2 and 3).

5.4.2 Affinity chromatography can quantitatively recover apoptotic DNA
Increasing numbers of radiolabeled, irradiated Raji cells were
processed by the affinity chromatography and the isopropanol
precipitation methods in parallel. The DPM of the DNA purified by the
affinity chromatography method correlated linearly with the number
(104 to 107) of cells (Figure 31 A). In addition, there was good
correlation between the two purification methods (Figure 3IB). Since
the apoptotic index in these cells was approximately 10% (data not
shown), this method was able to purify apoptotic DNA from as few as
103 cells.

5.4.3 Affinity chromatography purifies cleaner apoptotic DNA than
alcohol precipitation
Parallel cell samples were processed by affinity chromatography
or by isopropanol precipitation with or without the addition of RNase in
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Figure 31. Correlation of DNA recovered by affinity chromatography
with the number of cells processed (A) and with the DNA recovered by
isopropanol precipitation (B).
Apoptotic Raji cells were used to
evaluate the recovery of apoptotic DNA by the classical alcohol
precipitation method and the affinity chromatography method described
here. Raji cells were labelled with 0.1 pCi/ml 3H-thymidine for 72 h,
irradiated (2750 rad), and recultured for 24 h. Fragmented DNA was
purified by the affinity chromatography or isopropanol precipitation
methods from samples containing 103 to 107 cells. Amount of
recovered DNA was measured by scintillation. Curve fitting and r2
calculations were done with CricketGraph software.
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Figure 32. Agarose gel electrophoresis of DNA purified by affinity
chromatography or isopropanol precipitation.
Agarose gel
electrophoresis was used to evaluate DNA purified from apoptotic and
non-apoptotic PBMC by four methods. PBMC were isolated from
heparinized human blood by density centrifugation and aliquotted (1 x
106 cells). Non-irradiated samples were processed immediately as nonapoptotic controls (lanes 1-4). Samples irradiated (600 rads) to enhance
apoptosis were cultured overnight before being processed (lanes 5-8).
Lanes 1 and 5 were processed by isopropanol precipitation as described
by Duke and Cohen. Lanes 2 and 6 were also processed by isopropanol
precipitation, but the DNA was redissolved in RNase-containing
loading buffer. Lanes 3 and 7 were processed by affinity
chromatography using the manufacturer's lysis solution (1% SDS,
0.2 M NaOH). Lanes 4 and 8 were also processed by affinity
chromatography, but the cells were lysed in 1% SDS, without NaOH.
M = EcoRI/Hindlll digested lambda phage DNA. Molecular weights of
M are indicated to the left in bp.
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purified by affinity chromatography, and that this method is at least as
clean, fast, and efficient as the isopropanol precipitation method. This
method can be used to quickly purify apoptotic DNA for quantitative
analysis or to isolate mtDNA that is clean enough for non-radioisotopic
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Figure 34. Restriction digest identifies DNA purified from nonapoptotic cells as mtDNA.
Restriction digestion was used to
evaluate homogeneity of DNA purified from non-apoptotic cells. DNA
was isolated from Raji cells in log-phase growth by affinity
chromatography (IxlO6 cells/lane) using alkaline lysis. One sample
was cut with 20 units Hindi for Ihr before electrophoresis on 0.8%
agarose gel. mwm - EcoRI/Hindlll digested lambda phage DNA.
Molecular weights of mwm are indicated to the left in bp. Molecular
sizes of visible bands from Hindi-digested DNA are indicated in bp to
the right. Molecular sizes were determined using BioRad Gel Analysis
software. RFLP pattern for Hindi-digested mtDNA, morph 7, is
indicated at the far right.
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RFLP analysis. This method is a modification of a commercial method
that was developed for the purification of prokaryotic plasmid DNA.
When a neutral lysis solution was used, eluted apoptotic DNA formed
a clean oligonucleosomal ladder. However, when the alkaline Lysis
Solution was used, the eluted apoptotic DNA formed a smeared ladder
with faint bands that were approximately 75 bp apart, rather than the
typical 180-bp multiples. It is known that the covalently closed
plasmid DNA denatures at high pH, and rapidly reanneals at neutral
pH (Engebrecht et al., 1991). In contrast, the linear mono- and
oligonucleosomes of the apoptotic DNA are denatured at high pH into
single stranded DNA fragments that, being heterogeneous, reanneal
imperfectly and incompletely at neutral pH. I believe that these single
stranded and inaccurately renatured DNA fragments may explain the
smear of the ladder. In the past, these atypical smears formed by
apoptotic DNA after alkaline treatment have been attributed to
intranucleosomal "random fragmentation" (Kaeck et al., 1993) rather
than to faulty renaturation of mono- and oligonucleosomes.
The DNA recovery by this method was as good as the recovery by
the precipitation method up to a maximum cell load of 1-2 x 106
apoptotic human cells. The estimated DNA content of these cells is in
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good agreement with the advertised maximal DNA load of the column
(10 ^g). However, kits with greater capacity are also available.
Since the intact genomic DNA of non-apoptotic cells is removed
from the lysate by centrifugation before affinity chromatography, the
recovery of apoptotic DNA is probably not affected by an excess of nonapoptotic cells, as when the apoptotic index is very low. However, I
observed that radiolabeling may induce apoptosis in some cell lines, as
already reported by others (Solaiy et al., 1992). In my hands, DNA
purified from non-irradiated Raji cells cultured with 1.0 mCi/ml of
3H-thymidine was slightly fragmented (not shown). By radiolabeling the
cells with only 0.1 mCi/ml, I was able to reduce the background
apoptosis while retaining the sensitivity of the assay to detect as few
as 103 apoptotic cells after irradiation. However, radiolabeling probably
should not be used when the apoptotic index is low, as the background
apoptosis may overshadow the experimental apoptosis. Fewer
apoptotic cells should be detectable, even in conditions of low
apoptotic index, by using a DNA detection method that does not
damage the DNA during cell culture (Facchinetti et al., 1991; Huang
and Plunkett, 1992; Tilly and Hsueh, 1993).
The precisions of the alcohol precipitation and the affinity
chromatography methods were not directly determined here. However,
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the correlation of the DNA recovered with the number of cells
processed indicates similar precisions of the two methods. Since the
DNA is recovered in one step, affinity chromatography should be more
precise than alcohol precipitation, especially when multiple
precipitations/extractions are used, and when small amounts of DNA
are purified. Microamounts of DNA may not even form a visible pellet
after alcohol precipitation. In contrast, when purifying small amounts
of apoptotic DNA, affinity chromatography avoids the possible loss of
an invisible DNA pellet precipitated by ethanol.
This DNA purification method may also be used for direct
purification of mitochondrial DNA without having to first make crude
mitochondrial preparations. This was first suggested by the
appearance of a higher molecular weight band in apoptotic gels, which
was consistent with the 16kb supercoiled mitochondrial genome
(Figure 32 lanes 3, 4 and 7; Figure 33, lane 1). The covalently closed
circular nature of mtDNA makes the alkaline lysis affinity
chromatography purification directly applicable to purifying this DNA.
Any contaminating chromosomal DNA is denatured and the resulting
mtDNA is of sufficient purity for non-radioactive RFLP typing of cell
lines. Digestion of this DNA with the restriction enzyme Hindi
generated discreet restriction fragments, indicating that the digested
DNA was homogeneous. I believe that this may be an inexpensive and
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rapid method for monitoring the authenticity of cell lines in the
laboratory.
This mitochondrial DNA is probably also present in DNA purified
from apoptotic cells (Figure 32, lane 8), but cannot be easily
distinguished because it co-migrates with large apoptotic fragments.
Notably, a denser band is recovered when the neutral lysis buffer is
used (possibly indicating greater recovery of mtDNA or contamination
with early apoptotic fragments), but the band is not seen when
ethanol-precipitated DNA is electrophoresed since the detergent used
in this protocol, Triton X-100, is milder (Walker et al., 1993). Finally,
the use of a neutral lysis buffer might also be applied to adapting this
method to the purification of linear DNA fragments from transient
eukaryotic transfectants.
When fully compared with precipitation methods, this affinity
chromatography method has some more advantages (Table I), the major
being that the DNA preparation time is shortened from hours (or days)
to minutes, mostly because the method has no incubations, only one
centrifugation, and fewer total steps. Moreover, all the steps are done
at room temperature. Notably, the purified DNA is RNA free and
deproteination is done without phenol, thus avoiding DNA losses at
the chloroform:phenol interface as well as the hazards and pollution
problems associated with these solvents. Finally, the method is
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applicable to a wide range of cell numbers and is relatively inexpensive.
This protocol is now used in our laboratory routinely.
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